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Abstract
A biofilm, which is associated with 80% of chronic infections in humans, is formed when
bacteria aggregate, attach to a substrate and secrete a matrix protecting the bacteria from host cell
defenses and antibiotics. Bartonella henselae (B. henselae) is the causative agent of cat scratch
disease, persistent bacteremia, and one of the most frequently reported causes of blood-culture
negative endocarditis (BCNE) in patients. The ability of B. henselae to adhere to the heart valve,
form a biofilm and vegetation to cause endocarditis increases the morbidity and mortality rate in
infected patients. The presence of a trimeric autotransporter adhesin (TAA) called Bartonella
adhesin A (BadA) has been linked to biofilm formation in B. henselae. BadA is a protein of 3036
amino acids and a member of the TAAs found in Bartonella and other Gram-negative bacteria.
The function of BadA has been studied in vitro and is critical for agglutination, host cell adhesion
and activation of a pro-angiogenic host response. However, very little is known about badA gene
regulation or the molecular basis of biofilm formation. This work aims to determine whether BadA
is necessary for the establishment of biofilms and how the bacteria regulate badA expression.
Using genetic mutations, real-time cell adhesion assay, RT-qPCR, and microscopy, it was shown
that BadA is required for biofilm formation. Using an in-frame complete deletion strain of badA,
a reduced ability to form a biofilm was observed which was restored in the deletion strain
complemented with a partial badA. Analysis of the B. henselae transcriptome shows nine highly
transcribed, homologous RNAs, termed Bartonella regulatory transcript (Brt1-9). The Brts are
short-sized (<200 nucleotides), highly expressed, and located in an intergenic region indicative of
small RNAs (sRNA). The Brts are predicted to form a stable stem and loop structure with a

viii

potential terminator/riboswitch region on the 3′ end. Located ~20 nucleotides downstream of each
Brt is a poorly transcribed helix-turn-helix DNA binding protein gene termed transcriptional
regulatory protein (trps 1-9). High brt transcription stops just before the start of the trp implicating
the 3’ loop of the Brt as a terminating loop. Replacement of the trp with a gfp reporter gene shows
that in the absence of the 3′ end of Brt1, gfp is transcribed. Also consistent with our findings, an
increase in both the transcription of trp1 and badA and the formation of a biofilm in mutants of the
brt1 gene was observed. Furthermore, to determine the role of the Trp in regulating badA, an
electrophoretic mobility shift assay was carried out. The data confirms that Trp1 binds the
promoter region of badA gene to regulate gene expression. In summary, the brt1/trp1 regulon
affects badA transcription and biofilm formation in B. henselae. Understanding the mechanism
and condition(s) by which the brt/trp regulatory system regulates badA is a plausible approach to
the development of treatments that target the formation of biofilm-related diseases and persistent
bacteremia in humans.

ix

Chapter 1: Introduction
Note to Readers: Portions of this chapter are published in “Okaro, U., Addisu, A., Casanas, B.
and Anderson B. Bartonella Species, an Emerging Cause of Blood-Culture-Negative Endocarditis.
Clinical Microbiology Reviews, 2017. 30(3): p. 709-746.”, and has been included with permission
from the publisher.

1.1

Introduction to Bartonella Species
During World War 1, a disease plagued about 1 million soldiers in Europe including US

armies, one-fifth of the German and Austrian troops, and about one-third of the British forces.
Since then, the same outbreak has been reported in the United States, France, and Burundi [1-3].
This plague was called the ‘five-day fever,’ and in 1960, Bartonella quintana was isolated as the
etiologic agent [4]. Bartonella quintana belongs to the Bartonella genus, a group of fastidious,
Gram-negative, facultative intracellular pathogens with a unique intra-erythrocytic lifestyle. Other
species include Bartonella bacilliformis; the agent for Carrion’s disease and Bartonella henselae
(B. henselae); known for causing cat scratch disease (CSD). There are currently about 42 species
and subspecies in the Bartonella genus [5] that have been isolated from a variety of hosts such as
humans, rats, cattle, squirrels, cats, dogs, etc. [6-12]. The presence of Bartonella species in the
blood of these infected animal reservoirs usually does not lead to severe illness. This vast range
of infected animals, therefore, serves as a reservoir for potential zoonotic infection. Of the 42
species, 13 have been shown to infect humans with diseases like blood culture-negative
endocarditis (BCNE), verruga peruana, Oroya fever, lymphadenopathy, CSD, neuroretinitis, etc.
1

[5, 13-20]. Only two known species of Bartonella; B. bacilliformis and B. quintana, infect humans
as their host reservoir. These two species together with B. henselae cause the vast majority of
human diseases attributed to Bartonella species [21]. Bartonella is transmitted to mammalian
hosts through a variety of blood-sucking arthropods such as fleas, lice, ticks, and sandflies [22]. It
is known to adapt to the gut of the obligate, blood-sucking arthropod vector and to the erythrocytes
of the mammalian host signaling a heme requirement for growth [23, 24]. This requirement for
heme is met in the laboratory through the use of hemoglobin, erythrocytes or hemin added to agar
base and culture media.
Diagnosis of Bartonella infection is confirmed in the lab using PCR detection of the 16S
rRNA or by serological assays to detect specific antibodies in patient sera [14, 25-27]. Giemsa,
hematoxylin-eosin and Warthin-starry stains are used for histological detection of the bacterium
in infected tissues [28-30].
The genome size for Bartonella ranges from 1.45Mbp to about 2.6 Mbp. The species
associated with rodents possess larger genome sizes (from a range of 1.6- 2.6 Mbp) while the
species found in humans, B. bacilliformis and B. quintana have smaller genome size (1.45 - 1.5
Mbp) [31-33]. This genome size difference can be attributed to horizontal gene transfer because,
unlike the human-restricted species, the rodent-associated species carry more genes such as the
Type 4 secretion system (T4SS), trimeric autotransporter adhesin (TAA), and other adhesive genes
(e.g. outer membrane proteins and filamentous hemagglutinin) needed for host adaptability [33].
1.2

B. henselae
B. henselae was first isolated in 1992 from a febrile patient infected with human

immunodeficiency virus (HIV) [12]. B. henselae is endemic worldwide and commonly causes
long-term bacteremia in domestic and feral cats (Felis cattus). The transmission vector is the cat
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flea (Ctenocephalides felis) [34, 35] with about 50% of cats having serological evidence of
previous or current infection [36]. Transmission to humans occurs indirectly by inoculation of
contaminated flea feces through the scratch of a cat [37] and occasionally through a bite [38], but
cat-to-cat transmission by the cat flea without direct contact transmission has been demonstrated
[39]. Possible cat-to-cat transmission mechanisms include flea bite and ingestion of fleas and flea
feces [40]. There has been no data to confirm flea-to-human transmission to date [34, 38, 41].
Bacteremic healthy cats with B. henselae are associated with bacillary angiomatosis (BA)
and CSD in their human contacts. The majority of CSD cases occur in pediatric patients (age 5 –
9) and for people living in the southern United States in general. The estimates predict 22,000 CSD
cases in the United States each year, with approximately 2,000 hospitalizations. Most cases are
reported between September-January [42]. Some attribute the seasonal prevalence to cats breeding
patterns, the peak period of domestic cat adoptions, and the temporal presence of fleas on cats that
spread the bacteria among the cat population [42]. Bacteremic cats are more likely to infect fleas
resulting in flea vector persistence [43]. B. henselae is detected experimentally in oral swabs from
infected cats [38, 44], is capable of replicating in the gut of the cat flea, shedding and surviving in
flea feces up to 3 days after exposure [45-47].
1.3

Human Diseases and Treatment
1.3.1 Endocarditis.
Also called infective endocarditis (IE), is an inflammation of the inner lining of the

heart.Bacterial endocarditis, the most common type, occurs when bacteria attaches and grows in
the heart. B. henselae and B.quintana represent 90% of all cases of endocarditis caused by
Bartonella species [48]. In patients with other bacterial agents endocarditis such as staphylococcal
endocarditis, B. henselae may also be involved as a co-infectant [49]. Bartonella endocarditis
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usually occurs in people with a history of past valve diseases, cat or cat flea exposure [48-50]. B.
henselae and B. quintana exhibit tropism for endothelial cells and are able to replicate and persist
in endothelial cells.
1.3.2 Cat-scratch disease (CSD).
B. henselae causes CSD in humans and is transmitted by a cat’s scratch, bite or lick [51].
A cat bite or scratch followed by local inflammation 10-14 days later and significant enlargement
of regional lymph nodes (lymphadenopathy) are the classic symptoms of CSD. Systemic
symptoms like fever and malaise typically develop and could last for several weeks. Most cases
are benign and usually resolve spontaneously in immunocompetent persons. Severe complications
such as meningitis, osteomyelitis, encephalitis, and endocarditis are also known to occur primarily
in immunocompromised individuals [52, 53]. Occuloglandular syndrome (also called Parinaud’s
occuloglandular syndrome) is an ocular symptom of CSD of granulomatous conjunctivitis with
pre and postauricular lymphadenopathy; an earlier case report highlights an increasing spectrum
of ocular involvement by CSD presenting as an optic nerve granuloma [54, 55]. Studies show that
more than 50% of domestic cats are Bartonella carriers but seldom show signs or symptoms of
infection [41, 56, 57]. The cat flea mainly transmits the bacteria between cats although other
arthropods, mainly ticks of the genus Ixodes are implicated as vectors [58].
1.3.3 Bacillary Angiomatosis (BA).
BA is a vascular endothelial proliferative disease that develops as a single or multiple
papulonodular cutaneous lesions. The etiologic agents are B. henselae and B. quintana [13, 25,
59]. BA was initially described in patients with HIV but is also described in both
immunocompetent hosts [60] and in immunocompromised status such as organ transplant
recipients on immunosuppressive therapy. The cutaneous lesions are highly vascular, bruising or
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easily bleeding; due to the underlying effect of these species of Bartonella causing abnormal
vascular endothelial cell proliferation and neovascularization [61, 62]. Studies have shown
multiple mechanisms for this characteristic of Bartonella species causing endothelial and vascular
proliferation. The reported mechanisms of pathogenesis include vascular endothelial growth factor
(VEGF) induced capillary proliferation and mechanisms that inhibit apoptosis of vascular
endothelial cells through caspase inactivation and DNA fragmentation [63-65]. The skin lesions
may be superficial or deep into the subdermal structures, sometimes even involving the bones.
Regional lymphadenopathy, the involvement of mucous membranes of the mouth, conjunctivae
and the gastrointestinal tract including the perianal area has also been described. It is also known
that visceral involvement with the liver, spleen, lymph nodes and bone marrow can occur, with
other reports documenting isolated visceral role in the absence of skin lesions [66, 67].
1.3.4 Bacteremia.
Invasion of erythrocytes and continued intraerythrocytic presence in their respective
reservoir hosts (sometimes referred to as intraerythrocytic bacteremia) is an indication of
inoculation of a reservoir host by Bartonella species [68, 69]. Bartonella species use several
molecular mechanisms for erythrocyte invasion and immune response evasion that would
otherwise cause symptoms in bacteremic hosts [70-73]. Such asymptomatic bacteremia was
reported in various non-mammalian and mammalian hosts including humans [74-77].
Asymptomatic bacteremia can persist from a few weeks to several months in studies conducted in
healthy human volunteers [78]. In humans, a proportion of the erythrocytes, usually no more than
1% is infected by B.quintana, and such low-level bacteremia may persist with little or no
symptoms for months to years [69, 79, 80]. In a B.tribocorum infected rat model, B-cell deficient
rats had more prolonged bacteremia when compared with immunocompetent rats [80, 81]. It is
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likely that low-level bacteremia may herald the pathogenesis and the clinical development of
endocarditis in humans; however, this has not been confirmed [82].
1.3.5 Treatment considerations for Bartonella endocarditis.
Bartonella species can evade the host immune system and resist antimicrobial agents as a
result of their pathogenic and virulence mechanisms, particularly their ability to persist in a
primary niche [69, 83-86]. Earlier studies have shown that numerous Bartonella species are
commonly susceptible to several classes of antibiotics, including beta-lactams, macrolides, and
aminoglycosides [86-88]. Despite being susceptible at low minimal inhibitory concentrations
(MIC), subsequent studies and clinical experience have shown that treatment failures for
Bartonella infections are a significant problem [89-91]. Some of the antimicrobial classes tested
against Bartonella show only bacteriostatic properties except for aminoglycosides such as
gentamycin. In cases of Bartonella endocarditis, the issue of host defense evasion, potential
biofilm formation, and antimicrobial resistance is even more crucial as cultures are likely to be
negative and diagnosis delayed. Based on experience from the past two decades in the treatment
of Bartonella endocarditis, multiple reports and recommendations advocate the use of at least two
antibiotics, one of them being an aminoglycoside [92-94]. The recommended duration of therapy
is generally for a minimum of 4 weeks in native valve disease and 6 weeks in prosthetic valve
endocarditis. Aminoglycosides are recommended at least for the first two weeks of therapy. The
duration of aminoglycoside use and the total duration of therapy correlates with clinical outcomes
with longer duration conferring mortality benefit [95, 96]. However, in cases where antibiotics
fail, surgical resection of the infected heart valve may be required [97].
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1.4

B. henselae pathogenesis
The Toll-like receptors (TLR) are a type of pattern recognition receptor (PRRs) which are

used by the innate immune system to detect pathogens. Bartonella can evade immune system
recognition because of the reduced endotoxin activity of the lipopolysaccharide in the outer
membrane of the bacterium. After inoculation via an intradermal or intravenous route, Bartonella
evades the host innate immune system for the primary niche, hypothesized to be a biofilm
community and grows within the biofilm [98]. A biofilm is defined as a community of bacteria
irreversibly adherent to a surface and embedded in an exopolysaccharide matrix. Biofilms form in
five steps, initial adhesion, irreversibly attachment, maturation steps 1 and 2, and dispersion [99].
Growth in a biofilm enables B. henselae to maintain a presence in the flea feces and in the reservoir
host (cat) and to evade the host immune system during human infection. Dispersion is a crucial
stage as cells are released from the community to colonize new surfaces and form a new
community. During a relapse, cells are dispersed from the biofilm to re-infect the blood causing
bacteremic relapse [69].
1.5

B. henselae virulence factors
Most Bartonella species possess a VirB/VirD4 T4SS and surface appendages initially

described as type IV pili comprised of TAA with the exception of a few which possess one or the
other [31, 68, 100, 101]. TAAs are outer membrane proteins found on many other Gram-negative
bacteria and shown to be involved in bacterial agglutination as well as facilitating adhesion to
extracellular matrix components and host cells. Bartonella species and most Gram-negative
bacteria possess TAAs [102-105]. B. henselae possess two dominant virulence genes which
facilitate infection: the TAA called Bartonella adhesin A (BadA) and the VirB T4SS [106, 107],
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as well as a range of other genes like the T4SS Trw [108], filamentous hemagglutinins [109, 110]
and outer membrane proteins [5].
1.5.1 VirB/VirD4 Type IV secretion system
T4SSs are transporters found in Gram-negative bacteria and are used to translocate
virulence factors into host cells [111]. T4SSs are present and also characterized in other Gramnegative bacteria including Helicobacter pylori, Agrobacterium tumefaciens, and Legionella
pneumophila [69, 112-114]. The VirB/VirD4 T4SS in B. henselae is the most characterized T4SS
among the genus as reviewed in Harms et al. 2012 [68]. Schulein and Dehio (2002) [114], reported
that the VirB/VirD4 is used to colonize the vascular endothelium and promotes a VirB/VirD4dependent inhibition of apoptosis [114]. It is also used to translocate the Bartonella effector
proteins (Beps A-G) into the host cell resulting in an invasome mediated uptake, activation of a
proangiogenic phenotype and inhibition of apoptosis [115].
1.5.2 Bartonella adhesin A (BadA).
TAAs have been studied extensively in other Gram-negative bacteria like the YadA of
Yersinia enterocolitica, NadA of Neisseria meningitidis, Hia and Hsf of Haemophilus influenzae
[103, 116-119]. BadA is a TAA protein found in B. henselae and is the longest known protein in
the TAA family at 328 kDa per monomer and almost 1 million Daltons for the trimer. It forms
filaments reported to be as long as 240nm on the surface of B. henselae [102, 120]. As all TAAs,
BadA is characteristically made up of a head domain, a stalk region, and a C-terminal membrane
anchor. The BadA head is responsible for auto-agglutination and adherence to the host
extracellular matrix (ECM) and the stalk region is required to bind fibronectin [121]. The Cterminal membrane anchors the whole protein to the bacterial outer membrane, oligomerizes the
stalk domain and aids movement of the polypeptide chain through the cell membrane [105, 122].
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The length and molecular size of the TAA also vary between species and this variation is thought
to be related to the size of the neck/stalk region [100, 123, 124]. Trimerization is required to
maintain the stability and adhesive property of the protein [118]. BadA is known to aid adherence
of bacterial cell to host cell and extracellular matrix protein including fibronectin [125]. BadA is
required for secretion of vascular endothelial growth factor (VEGF) from the host cell [125].
Regulation of badA is linked to the BatR/S two-component system, the general stress response
system and a family of nine unannotated and highly transcribed RNAs designated as Bartonella
regulatory transcript (Brt1-9) found upstream of a transcriptional regulator [110, 126, 127]. In
Quebatte et al. (2009) [110], a ΔbatR mutant showed differential downregulation of badA as time
increases post-human endothelial cells infection but overall upregulation of badA over 48 hours
when compared with the wildtype. Tu et al. (2016) also showed that the Brt1 RNA and the Trp1
regulatory protein affected badA transcription and biofilm formation negatively and positively
respectively. An antisense knockdown of brt1 shows upregulation of badA transcription and
biofilm formation and overexpression of the trp1 gene also upregulated badA biofilm dependent
formation [128].
1.5.3 T4SS Trw.
T4SS Trw is a second surface localized T4SS acquired during evolution of bartonellae and
discovered in B. henselae by Suebert et al. (2003) [108]. It is present in 13 species that adapt to
diverse mammalian reservoir hosts and absent from human-specific B. bacilliformis, cat-specific
Bartonella clarridgeiae and the species of the ruminant-specific sub-branch, which all diverted
early during the evolution of the bartonellae [129]. The presence and function of flagella and the
Trw T4SS were hypothesized to be mutually exclusive [111]. It is required for intraerythrocytic
adhesion, invasion, and survival but dispensable for endothelial cell infection [130, 131].
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1.5.4. Other outer membrane proteins
Filamentous hemagglutinin (Fha) is present in eight copies of varying lengths in B.
henselae and is known to mediate adhesion in Gram-negative bacteria [132, 133]. Fhas are
reported to be controlled by BatR, the sensor partner of the two-component system, BatR/S [110].
In addition to BadA and Fhas expressed on the outer membrane of B. henselae, outer membrane
proteins (OMPs) are also found in Bartonella. OMP43, a 43-kDa protein is a major porin protein
reported to be involved in proliferation and binding endothelial cells [134, 135]. In B.quintana, the
variably expressed outer membrane proteins (VOMPS) are reported to be involved in
autoaggregation and collagen binding [136].
1.6

Biofilm Regulation
The ability to adhere and auto-aggregate is an essential aspect of biofilm formation as it

enables the bacteria to form microcolonies and ultimately form a biofilm [5]. A biofilm is a
community of adherent cells protected by an extra polymeric substance (EPS) and able to survive
transient exposure to antimicrobial substances. The ability to survive and tolerate this exposure to
antimicrobials relates to bacterial persistence and the relapse of chronic infection after treatment.
Bacteria cells are seeded from a biofilm during the dissemination/dispersion step to form a new
biofilm. As previously mentioned, the first step of biofilm formation is surface adhesion and
agglutination facilitated by outer membrane proteins. Once bacteria agglutinate, they communicate
effectively using chemical signaling molecules. This signaling process called quorum sensing (QS)
enables bacteria to track changes in the environment triggering changes in gene expression [137].
Biofilms are typically stable, involved in chronic infection and relapse, and display increased
resistance to antibiotics and host immune response. Microbial biofilms are implicated in a variety
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of diseases: dental plaque, chronic lung infection in cystic fibrosis patients as well as heart valve
vegetations in patients with infective endocarditis as reviewed in Bjarnsholt (2013) [138].
In many Gram-negative bacteria, TAAs are linked to adhesion, the first step in biofilm
formation [139]. B. henselae biofilm growth was first reported by Kyme et al [140], which
describes the aggregates as a phase variation, a property now shown to be attributed to the presence
or absence of BadA on the surface [100]. Growth characteristics were thought to be associated
with variation in genotype and OMP expression. BadA accumulates as a dense surface layer
hairlike structures ( ̴240nm) and its absence prevents auto-agglutination [125]. The role of TAAs
in biofilm formation has been proposed or experimentally demonstrated for a wide range of Gramnegative bacteria including Acinetobacter baumanii [141], Burkholderia species [142, 143],
Escherichia coli UPEC and EHEC [139, 144] and Salmonella enterica [145]. Previously published
reports by Okaro et al. (2017, 2019) [5, 98] show that BadA is linked to biofilm formation. An inframe deletion mutant of the badA gene displayed a severely, reduced ability to form biofilms.
Scanning electron micrographs of B. henselae biofilm also show aggregates similar to the
vegetative mass observed in patients with BCNE. It was speculated that biofilms bolster
transmission of the bacteria from the arthropod vector [98]. B. henselae has been shown to grow,
replicate and persist in the cat flea gut, and is excreted in the cat flea feces [35, 47, 146]. A biofilm
EPS is typically made up of eDNA, proteins, polysaccharides and other excreted components
[147].
1.7

Non-coding RNAs
The regulatory circuit for biofilms is initiated once bacteria adhere to a surface. RNAs have

been implicated in the regulation of genes which control biofilm formation in B. henselae and
other Gram-negative bacteria [128, 148, 149]. Since the discovery of the first signaling RNA [150],
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RNAs have been shown to work through a variety of approaches like regulating transcription,
translation, DNA silencing, and mRNA stability [151]. Genome-wide studies show that a high
percentage of RNA molecules within the bacterial genome are transcribed as non-coding small
RNA (ncRNA) [152].
ncRNAs are small-sized, post-transcriptional regulatory molecules that regulate bacterial
physiology like metabolism, communication and biofilm formation [153-155]. ncRNA may
function as trans-acting antisense transcript (asRNA) or as cis-acting RNA. ncRNA expression
changes in response to environmental conditions such as pH, nutrient availability, antimicrobial
peptides and competition with other microbes as reviewed in Ortega et al. (2014) [156].
Bartonella regulatory transcripts 1-9 (Brts 1-9), previously described by Tu et al. (2016)
[128], are a family of highly expressed, multi-copy sRNAs specific to Bartonella species (Fig
1.1c). The Brts are found in a location of the B. henselae genome known to harbor a novel genomic
region enriched in repeats and highly expressed genes with proteins of unknown function (Fig
1.2a) [157]. This high repetitive characteristic is indicative of a horizontally acquired gene which
may have been duplicated. The Brt RNAs are also highly conserved (Fig 1.1b, 75-100%) and the
number of RNAs vary between species [128]. Nucleotide alignment of Brt 1-9 show that
nucleotide conservation is maximal at the 3' end of the gene (Fig 1.1b, red box), a location
predicted to fold into a highly stable stem and loop structure requiring very low Gibbs energy (Fig
1.1a, red circle). Tu et al. [128] also showed that knocking down the highly expressed brt1
positively affected the expression of badA/BadA involved in biofilm formation. This evidence
suggests that a native Brt1, a ncRNA, negatively regulates badA expression.

12

Fig 1.1. Characteristics of Brt1 and Trp1. A. Predicted secondary structure of Brt1. B. Conservation areas of the Brts (red box
shows 3' region). C. RNA-seq analysis showing the reads and direction of the nine Brts. Green indicates transcription (left to right
5’ to 3’) in the direction depicted, red indicates transcription in the reverse direction (right to left as indicated) and yellow indicates
regions with ambiguity (Brt4 and Brt9 have identical sequences). D. The conservation of the Trps. The blue box depicts
conservation around the HTH domain.

1.8

Riboswitches and RNA thermometers.
Riboswitches and RNA thermometers (RNAT) are regulatory cis-encoded sRNAs which

fold into intricate structures in response to metabolites or environmental changes (pH, temperature)
to modify the expression of a downstream gene [158, 159]. These intricate structures are typically
found in the 5' untranslated region (UTR) of the gene which is being regulated (reviewed in Jameel
M. Abduljalil (2018) [159]). Riboswitches can sense metabolites like amino acids, carbohydrates,
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co-enzymes, hemoglobin, metal ions like magnesium, environmental conditions like pH while
RNATs monitor temperature changes only [160, 161].
Downstream and in the same direction as each brt gene described above, is a gene which
codes for a DNA transcription factor called Transcriptional regulatory protein, Trp1-9 (Fig 1.1c).
Like the brts, the trps are also present in multiple copies and conserved at the amino acid level
(65-100%), especially around the characteristic helix-turn-helix xenobiotic response element
domain (Fig 1.1d, blue box). Under the conditions used for the RNA-seq in Tu et al.,[128], the
trps were minimally transcribed (Fig 1.1c) . Each brt and the accompanying trp are arranged sideby-side with less than 15 nucleotides separating the tentative end of a brt from the open reading
frame (ORF) of the corresponding trp gene (Fig 1.2b), thus reducing the possibility of a native trp
promoter. In view of the high transcript rate of the brt, the low transcript rate of the downstream
trp gene (Fig 1.1c), the close brt/trp gene arrangement without a discernible trp promoter (Fig
1.2b), and the stem and loop structure on the 3' end of the Brt1 RNA (Fig 1.1a- red circle), it is
feasible that the 3' loop of Brt1 RNA affects the downstream trp1 transcription by either acting as
a terminating or anti - terminating loop.Since riboswitches or RNATs respond to physical or
metabolic changes in the environment, the primary differences between the cat flea arthropod
vector and the mammalian hosts may signal the activation or repression of the trp gene. Some of
the differences between the arthropod flea and mammalian hosts are listed in table 1.1. Both
riboswitches and RNATs have been shown to regulate virulence genes including genes that initiate
biofilm formation.

14

Fig 1.2. Diagram showing the relationship between Brt1 and Trp1. A. Location of the nine Brt RNAs on the B. henselae Houston1 genome. The red oval indicates the region of the genome containing all nine Brt RNA family members. Genome map reproduced
from Omasits et al., 2013 with permission. The sequence of Brt1 and Trp1. Dotted lines represent Brt1 putative promoter, followed
by the Brt1 RNA (Red). Red, underlined sequence represents the 3' stem-loop found in Brt1. Black, italicized fonts show the
tentative Trp1 ribosome binding site within the intergenic region separating Brt1 and Trp1. The RBS is closely followed by Trp1
start codon (GTG) and coding region (Blue). B. henselae sequence adapted from NCBI Reference Sequence:
NC_005956.1:1438600-1439626.
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Table 1.1: Significant differences between the arthropod vector mammalian host of B. henselae.

Factor

Arthropod Vector

Mammalian system

(cat flea)

(cat and human)

Temperature

̴13-35°C [162, 163]

36.5-37.5°C [164]

Heme

0 mM to 5 mM [165]

0.5 μM (Free heme in the blood) [166]

pH

6.0-6.8 [167]

7.34-7.45 [168]

1.9

Transcription factors
Proteins play a significant role in gene expression either by initiating transcription,

translation or modifying expression at the post-translational level. Transcription factors (TF) are
proteins which bind specific DNA sequences to regulate expression of a downstream gene by
either binding the promoter region to successfully initiate gene transcription or as repressor
proteins that inhibit transcription. TFs have been shown to affect biofilm formation by either
directly affecting transcription of genes related to biofilm or indirectly through a secondary
regulatory cascade [169].
Further analysis of the TF gene (trp1) found downstream of brt1 shows that the Trps have
a helix-turn-helix (HTH) domain and are xenobiotic response elements (XRE). XREs are the
second most frequently occurring transcription factors in bacteria and are known to control
metabolic and virulence genes [170, 171]. HTHs are functional motifs capable of binding the major
groove of DNA. Typically the second helix recognizes and binds the sequence while the first helix
stabilizes the protein DNA interaction binding as a dimer [172, 173]. HTH-XRE proteins typically
make specific DNA contacts through their N-terminal domains, but their DNA binding affinity is
modulated by their C-terminal domains [174]. MrpJ, a helix-turn-helix (HTH) xenobiotic response
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element (XRE) family transcriptional regulator found in P.mirabilis serves as a switch between
motility and adhesion [175]. BswR, an XRE family transcriptional regulator is involved in the
regulation of P. aeruginosa swarming motility and biofilm formation [176]. Tu et al. [128] showed
that trp1 is a positive regulator of badA. An overexpressing trp1 construct demonstrated increased
badA expression and biofilm formation.
1.10

Summary
Gene expression in bacteria is continuously regulated for overall fitness in any given

environment. sRNAs, TF and other regulators may activate or repress a specific gene. Some
regulators respond to a specific factor like temperature, while others respond to a plethora of
conditions, metabolites, ligands pH, ions, etc. Jointly, both TF and sRNAs regulate genes with a
variety of cellular functions, communicating with genes through a multifaceted network. We
hypothesize that one such network is the brt-trp-badA network which is used to control biofilm
formation in B. henselae. As previously explained, B. henselae has to respond to quick changes in
the environment (arthropod-mammal) to successfully colonize and live within a host system. It has
also been shown that sRNAs and TFs regulate virulence genes including genes responsible for
adhesion and biofilm formation by other bacteria. We propose that this novel arrangement between
an RNA and a TF affects badA transcription thereby controlling adhesion and biofilm formation
in B. henselae. This thesis focuses on the function of the 3' loop of Brt1 as a potential terminator/
anti-terminator to control the transcription of the TF gene downstream-trp1- which is shown to be
a positive regulator of badA. Finally, we studied the relationship between Trp1 protein and
transcription of the badA gene, a significant virulence gene in B. henselae.
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CHAPTER 2: B. henselae requires BadA for optimum biofilm formation

Note to Readers: Portions of this chapter are published in “Okaro, U., et al., The trimeric
autotransporter adhesin BadA is required for in vitro biofilm formation by Bartonella henselae.
npj Biofilms and Microbiomes, 2019. 5(1)” and included with permission from the publisher.

2.1.

Background
B. henselae is transmitted to the cat through the cat flea. It is transmitted to humans by

infected flea feces through the scratch of a cat. BadA is a TAA implicated as one of the major
proteins responsible for attachment and aggregation, the first step of biofilm formation in B.
henselae. The expression level of badA have been shown to correlate with biofilm formation [120,
128]. Biofilms are implicated in both parts of the B. henselae life cycle. B. henselae can colonize,
replicate and persist in the cat flea. It is excreted in flea feces and detected in both fleas and feces
at least 12 days post-infection [177]. Biofilm formation increases not only the persistence of
bacteria but also the transmission efficiency from the flea to the vertebrate host. Longer viability,
therefore, increases the likelihood of human transmission. Secondly, B. henselae biofilms are an
essential component of the vegetative growths observed in the heart valves found in BCNE patients
as reviewed in Bjarnsholt (2013) [138]. B. henselae can form a stable biofilm in patients with
infective endocarditis and surgery is often required to eradicate the biofilm [138].
Biofilms grow as three-dimensional structures in their natural environment. We used a 3dimensional nanofibrous scaffold, previously used to grow tumor cells, to model biofilm growth
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accurately in vitro [178]. As a more reproducible and information-rich alternative to the traditional
crystal violet assay, the xCELLigence real-time cell analysis (RTCA) system was used for
monitoring biofilm dynamics continuously throughout the entire assay. In this system, adherence
of bacteria to gold microelectrodes embedded in the bottom surface of xCELLigence microplates
(e-plates) impedes the flow of current between electrodes. This impedance signal reported as the
cell index (CI), provides a composite assessment of cell number, cell size, and cell substrate
attachment [179]. As bacteria grow, the close interaction between adhering cells begins to impede
the flow of current. Importantly, neither the gold electrodes nor the weak electric field perturbs
bacterial adhesion or growth [180].
In this chapter, we investigate the role of badA expression in biofilm formation and the
components and conditions favorable for biofilm formation.
2.2.

Materials and Methods
2.2.1. Bacterial Strains.
E.coli strain DH5α (Invitrogen 18258-012), B. henselae Houston-1 [12], B. henselae

Houston-1 ΔbadA [181] and B. henselae Houston-1 ΔbadA/pNS2PTrcbadA [98] were all used for
this study (Table 2.1). E.coli DH5α cells were grown at 37°C on either LB agar or in liquid LB
broth. B. henselae was grown on heart infusion agar supplemented with 1% bovine hemoglobin or
liquid Schneiders media (Sigma Aldrich, S9895) supplemented with 10% fetal bovine serum for
three days as described by Riess et al. [182]. Growth conditions were kept at 5% CO2 at 37°. Lima
et al. (2014) described B. henselae Houston-1 ΔbadA, a non-polar in-frame deletion mutant of
badA [181].

B. henselae Houston-1 ΔbadA/pNS2PTrcbadA, a partial complement of badA

consisting of the N-terminal head, a truncated neck region with only one neck domain, and the C-
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terminal membrane anchor was described by Okaro et al. (Fig 2.2b) [98]. B. henselae Houston-1
ΔbadA/pNS2PTrcbadA was grown on agar supplemented with kanamycin (50µg/ml).
Table 2.1 Bacterial strains and primers used for aim 2.

Strain/Primer sequence

Source/Sequence

B. henselae Houston -1

Regnery et al. 1992 [14]

B. henselae Houston-1 ΔbadA

Lima et al. 2014 [181]

B. henselae Houston-1 ΔbadA/pNS2PTrcbadA

Okaro et al. 2019 [98]

rpld F

ATGCGCATGACTACGAA

rpld R

CAGGGGCGAAGATGTTTAAG

badA screen 1F

ACGCATGTAGAGAATGGTGA

badA screen 1R

CTTCGCATCTTCAAGCACTATCT

2.2.2. B. henselae forms a biofilm
Bacteria were inoculated on either a nitrocellulose membrane or the 3-dimensional
nanofibrous scaffold to visualize and quantitate the amount of biofilm formed by B. henselae. The
3D nanofibrous scaffold designated as 3P was produced by electrospinning polylactic-co-glycolic
acid (PLGA), polylactic acid (PLA) and mono - methoxypolyethylene glycol (mPEG) block
copolymer [178]. The scaffold/membrane was immersed in 100% ethanol for 15 secs, washed with
PBS, transferred to 96 well plates containing 50μl PBS and placed under UV wavelength light for
45 minutes to ensure sterility. The well was washed with 100µl of media, inoculated with 150µl
of the bacterial cells (106) and grown at 37°C, 5% CO2 for 8 hours. 50µl of media was added to
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each well and grown for 24 to 72 hours total. The scaffold/membrane was fixed overnight in a
mixture of 2% paraformaldehyde and 2% glutaraldehyde in 0.2M sodium cacodylate buffer, pH
7.2 with or without 0.15% alcian blue. Samples were washed 2x in 0.2M sodium cacodylate and
post-fixed for 30mins in 1% OsO4. The dehydration steps occurred using ascending alcohol
concentration (35% - 5min, 50%-5mins, 75% - 5mins, 90% - 5mins, 100% - 10mins 2x, 50%
hexamethyldisilazane (HMDS) + 50% of absolute EtOH- 10mins, Pure HMDS – 10mins).
Samples were air-dried overnight, mounted on adhesive carbon film and coated for 30secs with
Au/Pd (60; 40) at 16.40g/cm and 25mA. Joel JSM6490LV scanning electron microscope operated
at 4Kv was used to image the scaffolds and secondary images collected as TIFF/JPEG.
2.2.3. BadA expression in B. henselae constructs.
To confirm that our partial complement expresses BadA on the outer membrane, all three
strains were used for immunofluorescence microscopy. Briefly, bacterial cells were grown on a 6
well chamber plate coated with poly-l-lysine overnight to adhere. The wells were washed in PBS
and fixed with 4% paraformaldehyde for 20mins. Fixative was washed off, samples were blocked
with 5% nonfat milk for 1 hour and washed again. The slide was incubated for 1 hour with 40µl
of anti-BadA rabbit antibody (1:200) and 40 µl of a 1:10,000 dilution of fluorophore-conjugated
secondary (Alexa 488 anti-rabbit) subsequently. The slide was washed, mounted and air-dried
overnight. Images were exported as TIFF.
2.2.4. badA expression within a biofilm.
As the expression of badA diminishes after multiple passages, we routinely used B.
henselae Houston-1 from a frozen stock stored at -80°C and the bacteria were discarded after four
passages to prevent loss of adhesin expression [100]. To compare the expression of badA in a
biofilm or in growth as planktonic cells, B. henselae was cultured in Schneiders liquid media at
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37°C, 5% CO2 for three days on a six-well polystyrene plate (Corning 3506) with or without mild
shaking at 100rpm. The supernatant was carefully aspirated to prevent biofilm disruption. The
biofilm was gently washed twice with PBS, and the RNA is extracted by directly adding trizol
(Life Technologies, 15-596-026) to the plate. The planktonic growth was pelleted and resuspended
in trizol. 10µg of the resulting RNA was treated with DNase (Thermo Fisher Scientific, AM1907),
and 1µg reverse transcribed to cDNA using the iScript cDNA synthesis kit (BioRad, 1708891).
RT‐qPCR was performed in a total volume of 25 μl which consist of 12.5 μl of the 2X Maxima
SYBR green/fluorescein qPCR kit (Thermo Fisher Scientific, K0241), 300 nmol of the forward
and reverse badA primers (screen 1F and 1R) (Table 2.2), and 2μl cDNA. The 50S ribosomal
protein L4 (rplD), was used as the reference gene for normalization. The reaction conditions were
as follows: a single cycle of 95°C for 3 mins, 40 cycles of 95°C for 10 s, and 60°C for 30 s,
followed by 95°C for 45 s and 55°C for 1 min. Melt curve analysis was used to confirm that primer
dimers were not generated. The comparative CT method was used to analyze data [183]. RT-qPCR
experiments were conducted as independent replicates and mean values compared between groups
using the student’s t-tests. SigmaPlot software (Systat Software, San Jose, CA) was used for
statistical analysis. Differences between groups were statistically different for a P-value <0.05.
2.2.5. The role of BadA in biofilm formation.
The xCELLigence® RTCA (ACEA Bioscience Inc.) was used to measure and monitor cell
adherence. This system measures cell adherence by recording the electrical impedance signal from
adherent cells on the bottom of specialized 96 well e-plates (ACEA, Biosciences Inc.) with gold
micro-electrodes. Maximum CI is achieved when the surface of the microelectrode is covered by
cells giving a constant CI. This saturated CI remains constant during biofilm formation but
decreases during detachment [179].

106 cells were seeded onto the plates, and real-time
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measurement occurred every 15 mins over 48-72 hours. The growth conditions were kept at 37°C
and 5% CO2. Post incubation, wells were washed with sterile water to remove planktonic cells and
stained with 0.1% crystal violet solution for 15mins to determine the amount of biomass in each
well. The wells were decolorized using 30% acetic acid, and the absorbance at 550nm was
measured. For each RTCA experiment, individual strains were seeded in 6 different wells and
averaged. The mean values were compared between groups using the student’s t-test.
2.2.6. The viability of cells within a biofilm
CLSM was used to confirm the components of a B. henselae biofilm. The 96 well e-plates
used for real-time monitoring were gently washed to prevent biofilm disruption. Molecular probes:
Film tracer biofilm viability kit (Invitrogen, L10316) containing STYO9 and propidium iodide
(PI) was used to stain wells according to the manufacturer’s protocols. Wells were stained for 30
mins, washed twice with sterile water and imaged immediately after the final wash. Samples were
examined using an Olympus Fluoview FV1000 microscope and image exported as TIFF.
2.2.7. Characterizing the components of a B. henselae Houston-1 biofilm.
The 96 well e-plates used for real-time monitoring were gently washed to prevent biofilm
disruption. Molecular probes capable of binding DNA (Hoechst stain (Thermofisher, 33342)),
proteins (Sypro ruby biofilm matrix stain (Invitrogen, F10318)), and polysaccharides (Wheat germ
agglutinin fluorescein conjugate (Invitrogen, W834)) were used to stain wells according to
manufacturer’s protocols. Wells were stained for 30 mins, washed with sterile water and imaged
as described above.
2.2.8. Environmental factors required for optimal biofilm formation
To compare the rate of biofilm formation and gene expression under conditions that mirror
the arthropod vector and mammalian hosts in vitro, bacteria cells were grown under different
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environmental conditions: pH (6.6/7.2), temperature (27°C vs. 37°C), and treatments (proteinase
K, 10µg/ml and 1U/µl DNase1 at time of inoculation or 24 hours after inoculation). The
experiment was carried out using the same methods outlined in 2.2.4.
2.3 Results
2.3.1. B. henselae forms a biofilm.
To examine biofilm formation by B. henselae Houston-1, 10^6 bacteria in a 150µl volume
were inoculated into a 96 well polystyrene plate with a nitrocellulose membrane on the bottom.
The membrane was removed after 8 to 72 hours incubation and processed to track biofilm
formation. Scanning electron microscopy (SEM) was used to observe biofilms formed by B.
henselae Houston-1. Individual rods were observed to aggregate and form micro-colonies within
8 hours of inoculation (Fig 2.1a). These micro-colonies aggregate to form extensive, defined
colonies observed 24 hours post-inoculation (Fig 2.1b). Rapid growth and biofilm are observed 48
hours after inoculation (Fig 2.1c). At 72 hours of growth, EPS surrounds the mature biofilm (Fig
2.1d).

Fig 2.1. Scanning electron micrograph of B. henselae growth and biofilm formation from 8 hours (A), through 72 hours (D). A.
Cells attach within 8 hours, before aggregation and production of micro-colonies (B -24 hours). C. The aggregates undergo
tremendous growth in 48 hours to produce biofilm within 72 hours (D).
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2.3.2. badA is highly expressed within a biofilm
The transcription rate of badA in B. henselae grown in a biofilm was compared to
planktonic bacteria grown with mild shaking at 100 rpm to prevent adhesion. Using primers
specific to badA (Table 2.1), a significant difference in badA expression was observed between
the two growth methods (Fig 2.2a). badA was preferentially expressed in a biofilm community in
comparison to planktonic growth. Fig 2.2b shows the functional parts used for B. henselae
Houston-1 ΔbadA and B. henselae Houston-1 ΔbadA/pNS2PTrcbadA constructs. Fig 2.2c shows
that all three strains have no significant difference in growth rates confirming that the presence or
absence of badA does not impact growth. In fig. 2.2d, badA transcription in the wild type and
partial complement are observed. badA is significantly upregulated in the partial complement
because of the strength of the Trc promoter which drives badA expression. Finally, BadA is
expressed in both B. henselae Houston-1 and B. henselae Houston-1 ΔbadA/pNS2PTrcbadA.
Immunofluorescent microscopy using anti-BadA antibody and fluorophore-conjugated secondary
antibody on intact bacteria cells shows BadA expression in the BadA expressing strain and we
observe no fluorescence in the B. henselae Houston-1 ΔbadA strain (Fig 2.2e). This signifies that
badA/BadA is needed for adhesion of cells: the onset of biofilm formation.
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Fig 2.2. Growth rates and badA transcript levels in B. henselae constructs. A. badA transcript level from bacteria grown as a biofilm
or planktonic (P = 0.004). B. The partially complemented clone consist of the head region, membrane anchor and a truncated neck
region. C. Growth curve experiment between strains. D. RT-qPCR using primers specific to the badA head confirming a significant
difference in badA expression between all strains (P≤0.024). E. B. henselae Houston-1∆badA/pNS2PTrcbadA expresses BadA on
the surface. Confocal microscopy with anti-BadA antibody and fluorophore-conjugated secondary antibody. RT-qPCR bars
represent the average of 6 replicates and error bars represent the SEM.
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2.3.3. BadA plays a significant role in biofilm formation.
To assess B. henselae biofilm formation in real-time, the xCelligence RTCA system was
employed. All three strains (B. henselae Houston-1, B. henselae Houston-1 ∆badA [181] and B.
henselae Houston-1 ∆badA/pNS2PTrcbadA) adhered to the plate to varying degrees and at differing
times (Fig 2.3a-enlarged image).

In fig 2.3a, the Houston-1 parental strain adhered more

efficiently in the early stages of growth (<20 hours), but the B. henselae Houston-1 ∆badA
displayed a higher cell index (CI) that was statistically different from the B. henselae Houston-1
(p <0.001, students t-test) at the end of the experiment (80 hours). There was no significant
difference

between

B.

henselae

Houston-1

∆badA

and

B.

henselae

Houston-1

∆badA/pNS2PTrcbadA (P = 0.163, students t-test) at that same time point prompting the use of
microscopy and traditional endpoint biofilm assays to evaluate the B. henselae Houston-1 ∆badA
cells. Crystal violet (CV) stain on the e-plates post-real-time monitoring, shows that B. henselae
Houston-1 biofilm is statistically different from B. henselae Houston-1 ∆badA (P = 0.004) but not
significantly different from B. henselae Houston-1 ∆badA/pNS2PTrcbadA (P = 0.6) (Fig 2.3b).
Partial complementation of badA in B. henselae Houston-1∆badA/pNS2PTrcbadA using the strong
promoter (Ptrc), resulted in an intermediate level of biofilm formation (Fig. 2.3b). Despite the high
cell index recording from the RTCA system at 80 hours, using the standard CV biofilm method,
B. henselae Houston-1 ∆badA cells did not form as much biofilm compared to the BadA expressing
strains. To determine how much of each B. henselae cells did not adhere to the e-plate, the cell
density of the supernatant (OD600) was measured (Fig 2.3c). The B. henselae Houston-1 ∆badA
supernatant was the least adherent, indicating that BadA is vital for adherence of bacteria to a
surface. Both the real-time analytical experiment and the CV staining data confirm that BadA is
essential for optimal biofilm formation in B. henselae.
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Fig 2.3. B. henselae biofilm formation using a 96 well e-plate. A. Real-time cell index of strains at 37°C and 5% CO2, the magnified
area shows 0-20 hours. B. Biomass from B. henselae cells from plate used for graph 2a stained with 0.1% CV. Students t-test: *( P
= 0.004), **(P = 0.6). C. The density of supernatant aspirated from experiment 3a before staining with CV. Bars represent the
average of 6 replicates and error bars represent SEM. D. CLSM image of B. henselae biofilm populations using the STYO9/PI
live/dead staining after 3 days of incubation. White arrows depict cells with a partially disrupted membrane (yellow cells), white
circle depicts the concentration of dead population (red cells).
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2.3.4. badA expressing strains harbor more viable cells within a biofilm.
To determine the viability of cells in the B. henselae biofilm, we utilized a two
fluorescence cell viability kit containing SYTO9 green-fluorescent nucleic acid stain and the redfluorescent nucleic acid stain, propidium iodide (PI). Confocal laser scanning microscope
(CLSM) was used to investigate the cells stained with SYTO9 and PI. SYTO9 stains nucleic acid
hence it stains both live and dead cells but in the presence of PI, which penetrates disrupted
membranes, the SYTO9 is displaced and the cell fluoresces yellow for partial SYTO9
displacement or red for complete displacement. Both B. henselae Houston-1 and B. henselae
Houston-1 ∆badA/pNS2pTrcbadA cells growing in biofilms show more viable cells exhibiting
green fluorescence and few dead cells with yellow fluorescence (Fig. 2.3d, white arrows). In
contrast to the BadA expressing strains, the biofilm formed by B. henselae Houston-1∆badA
shows a large population of dead cells (Fig. 2.3d, white circle).
2.3.5. B. henselae biofilm contains polysaccharides, protein, and eDNA.
B. henselae Houston-1 was used to characterize the biochemical composition of the
biofilm. Scanning electron microscopy (SEM) was employed to examine images of the biofilm
produced by B. henselae grown on a 3-dimensional nanofibrous scaffold. In Fig 2.4 (top row, LR), SEM images show scaffold only, B. henselae Houston-1, B. henselae Houston-1 ∆badA and
B. henselae Houston-1 ∆badA/pNS2PTrcbadA cultured on the scaffold. As seen on the top row
images L-R, microscopic analysis showed that the wild-type, B. henselae Houston-1 exhibits
massive growth, adhesion, and aggregation in comparison to B. henselae Houston-1 ∆badA. The
B. henselae Houston-1 ∆badA/pNS2PTrcbadA displayed an intermediate level of growth and
aggregation. B. henselae Houston-1 ∆badA shows sparse adhesive and aggregative properties in
the reduced formation of micro-colonies. Using Alcian blue dye dissolved in glutaraldehyde and
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paraformaldehyde, the bacterial EPS was preserved to provide a quantitative image of the bacterial
biofilm (Fig 2.4, bottom row). The bottom images confirm that B. henselae Houston-1 produced
the most biofilm with a smooth layer covering a dense growth. Although the scaffold (white arrow)
is still visible, it is mostly covered biofilms. In contrast, B. henselae Houston-1 ∆badA
demonstrated a thin layer of biofilm (red arrow) with some bacterial cells bare and unprotected by
a matrix (yellow arrow). The bacteria still show minimal adhesion with reduced biofilm formation
despite a complete deletion of the badA gene B. henselae Houston-1 ∆badA. Finally, B. henselae
Houston-1 ∆badA/pNS2PTrcbadA exhibits an incompletely assembled biofilm showing that
complementation with portions of the badA gene can induce limited biofilm formation.

Fig 2.4. Scanning electron micrographs (SEM) images of B. henselae biofilms. Biofilms established on a 3P scaffold after 72 hours
incubation at 37°C and 5% CO2. The top row shows bacteria growth preserved by the addition of fixatives (aldehydes only). Bottom
row: Biofilm produced by each strain: EPS is preserved by the addition of cationic dye, Alcian blue. White arrow depicts bare
scaffold and yellow arrow depicts single bacteria rods not covered by EPS. Red arrow depicts weak biofilm.
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We investigated the presence of DNA, proteins, and polysaccharides in a B. henselae
biofilm using a confocal laser scanning microscope. An experiment was performed on the e-plates
used for the real-time cell adhesion monitoring. The plates were stained with dyes which are
capable of binding to polysaccharides (wheat germ agglutinin), protein (sypro ruby), and DNA
(Hoechst). Fig 2.5a shows dyes binding to the biofilm components confirming that a B. henselae
Houston-1 biofilm contains polysaccharides, proteins, and DNA.
To confirm the presence of both protein and eDNA in the biofilm, We measured the ability
of the two enzymes, - proteinase K and DNase1-, to inhibit B. henselae biofilm formation. The
RTCA experiment was repeated and cells were treated with proteinase K or DNase1 during
inoculation or 24 hours after inoculation. Real-time monitoring of B. henselae Houston-1 cells
cultured and treated with 10ug/ml of proteinase K resulted in a significant decrease (40%-66%
inhibition) in biofilm formation depending on treatment time (Fig. 2.5b). Similarly, treatment with
DNase1 (1U/µl) resulted in a slight reduction in B. henselae biofilm (22%-43% inhibition).
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Fig 2.5. Constituents of a B. henselae biofilm. A. CLSM images of B. henselae biofilm with WGA fluorescein (polysaccharides),
SYPRO Ruby (protein) and Hoechst (DNA). B. Effects of proteinase K and DNase on a B. henselae biofilm using RTCA show
that enzymes added at time of inoculation caused significantly less adhesion and biofilm formation compared to a 24-hour old
biofilm.

2.3.6. badA expression and biofilm formation are influenced by environmental
conditions.
The response of B. henselae to changes in environmental temperature and pH was
investigated. At a lower temperature that is consistent with the C. felis vector in the environment,
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the cell index for B. henselae 48 hrs post-inoculation was 15% more than the cell index at 37°C
which correlates with the cat or human host temperature (Fig. 2.6a). We compared the viability of
the cells within a biofilm in different temperature using the SYTO9/PI stain. A significant amount
of B. henselae cells are viable when grown at 37°C compared to cells grown at 27°C (Fig 2.6b).
Cells grown at 27°C displayed areas with red/yellow cells (white circle) indicative of disrupted
membranes and reduced viability. badA expression is also insignificantly upregulated at 37°C (P
≤ 0.022) supporting the hypothesis that at 37°C, B. henselae requires BadA to form a biofilm (Fig
2.6c).
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Fig 2.6. The optimum temperature for a B. henselae biofilm. badA expression and biofilm formation in B. henselae Houston-1 is
susceptible to growth conditions. A: cell adhesion and biofilm formation under different temperatures. B. CLSM image of B.
henselae biofilm populations under different temperatures using the STYO9/PI live/dead staining C. badA transcript levels from
bacteria grown at different temperatures (students t-test, * = P ≤ 0.022). RT-qPCR bars represent the average of 6 replicates and
error bars represent the SEM.
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The effect of pH on B. henselae biofilm was compared using growth media with a pH of
6.6 and 7.2. At both pHs, B. henselae cells form biofilms (Fig 2.7a). There was no statistical
difference between growth in media of varying pH. However, badA expression statistically differs
at a pH of 7.2 (Fig 2.7b, students t-test, P = 0.007). It is observed that the expression of badA gene
is optimal at the inoculation pH of 7.2, at day 1 and gradually decreases as a biofilm is formed (Fig
2.6c). Interestingly, the pH goes up during the initial stages of biofilm formation (24 hours) and
then declines at 48 hours for the BadA expressing stains, B. henselae Houston-1, and B. henselae
Houston-1 ∆badA/pNS2PTrcbadA. However, B. henselae Houston-1 ∆badA maintains a near
slightly basic pH throughout the experiment (Fig. 2.7c).
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Fig 2.7. Optimum pH of a B. henselae biofilm. A. Biofilm growth at varying pH. B. badA gene expression under different pH
(students t-test, * = P = 0.007). RT-qPCR bars represent the average of 6 replicates and error bars represent the SEM. C. pH of
each strain at inoculation, 24, 48 and 72 hours endpoints. pH values are determined with pH strips (images) and a pH electrode
(actual value).
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2.4 Conclusion
BadA is a TAA implicated as one of the major proteins responsible for attachment and
aggregation, the first step of biofilm formation by B. henselae [120]. To determine if B. henselae
forms a biofilm, the bacteria were cultured on 96 well polystyrene plates with cellulose membranes
at the bottom over 72 hours. After observing the presence of biofilms microscopically (Fig. 2.1),
we quantified the expression of badA in a biofilm and compared that to the expression level in
planktonic growth (Fig 2.2a). Using the three constructs described in table 2.1, we investigated the
differences in gene expression, cell viability, biofilm formation, and composition, and
characterized the conditions favorable for biofilm formation in B. henselae.
Given the size of BadA (328 kDa per monomer), numerous attempts to make a full - length
BadA complement proved unsuccessful, as others have also reported [184], so we opted to use a
partial complement bearing the functional domains of the full-length protein (Fig 2.2b). All three
strains showed comparable growth rates (Fig 2.2c), and it was not surprising that B. henselae
Houston-1 ΔbadA/pNS2PTrcbadA shows high levels of badA transcript compared to the wild-type
(Fig 2.2d). Fig. 2.2e shows surface localization of the truncated BadA; the levels of BadA protein
were not proportionally high as the corresponding mRNA observed in fig. 2.2d. Compared to the
native full - length BadA, the truncated protein may be more susceptible to protease degradation
or may be incompletely translocated to the outer membrane.
The microplate assay is one of the most commonly used methods for measuring in vitro
biofilms [185]. While it is inexpensive and straightforward, the data is sensitive to sedimentation
and loosely attached biofilms [186]. To avoid these issues, the xCelligence RTCA was used. High
cell index levels of B. henselae Houston-1 and B. henselae Houston-1 ΔbadA/pNS2PTrcbadA were
expected; however, the B. henselae Houston-1 ∆badA cell index was unanticipated because it
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lacked badA gene (Fig 2.3a). Growth rate experiments over 96 hours show that all three strains do
not significantly differ (Fig. 2.2c), hence the increased cell impedance from the B. henselae
Houston-1 ∆badA mutant was not due to increased growth rate and did not correlate with our
previous data showing that the mutant produced less biofilm in comparison to the wild-type [5].
At the end of the real-time monitoring, we determined the cell density (OD600) in the supernatant
of each strain. The OD600 recorded by B. henselae Houston-1 ∆badA was twice as high as B.
henselae Houston-1 and 10% more than B. henselae Houston-1 ΔbadA/pNS2PTrcbadA (Fig 2.3c),
therefore, the real-time analysis output was either adherent cells not present in a mature biofilm or
sediment from planktonic or dead cells. A crystal violet stain was used on the e-plates post-realtime monitoring to demonstrate that B. henselae Houston-1 ∆badA formed less biofilm, 13% in
comparison to B. henselae Houston-1, and 20% of the biofilm formed by B. henselae Houston-1
ΔbadA/pNS2PTrcbadA (Fig 2.3b). Despite the complete in-frame deletion of BadA, B. henselae
Houston-1 ∆badA still forms a biofilm that can be attributed to the presence of other outer
membrane proteins present on the bacterial surface that function as adhesins. An example is the
outer membrane proteins like Omp43 which bind endothelial cells (EC) [135] and Pap31 which
binds fibronectin [187].
Microscopic examination of the biofilm population on the e-plate post-real-time
monitoring using a confocal microscope show a profound biofilm surface apparent from the hazy
aggregates which give off a green fluorescence in B. henselae Houston-1 (Fig 2.3d). While the
majority of the B. henselae Houston-1 cells indicate an intact membrane confirming cell viability
within the biofilm, dead or compromised cells with a yellowish fluorescence (white arrows) are
observed. B. henselae Houston-1 ΔbadA/pNS2PTrcbadA did not exhibit as much biofilm as the
wild-type strain, but it displayed adhesive and aggregative properties with comparable cell
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viability to the B. henselae Houston-1. Although the RTCA real-time monitoring records the most
impedance from the B. henselae Houston-1 ΔbadA, the viability assay shows that a majority of the
bacterial population fluoresces red (Fig. 2.3d, white circle), which suggests that a significant
amount of the cells recorded by the gold electrodes are dead cells within the biofilm.
With a scaffold and staining methods previously described in Behnke O and Zelander T,
(1970) [188], we visualized the three - dimensional structures of the biofilms. Bacterial cells grown
on the scaffold formed aggregates around the scaffold, similar to those seen in in vivo infective
endocarditis. The biofilm formed maintained structural integrity through sample processing. In
Fig 2.4, the top row shows a 3-dimensional image of the scaffold followed by images of bacteria
grown on a scaffold. B. henselae Houston-1 and B. henselae Houston-1 ΔbadA/pNS2PTrcbadA both
show bacterial aggregates with the B. henselae Houston-1 exhibiting massive growth enveloping
the scaffold surface. Growth and adhesion to scaffold branches by B. henselae Houston-1 ΔbadA
were reduced compared to the BadA expressing strains. Alcian blue is a cationic dye known to
stain and preserve the structure of polysaccharides by binding carboxyl or sulfate groups present
in glycosaminoglycan/mucopolysaccharides to form an insoluble complex [188]. B. henselae
Houston-1 shows a smooth solid mass of biofilm covering the scaffold (Fig. 2.4, white arrow)
while B. henselae Houston-1 ΔbadA/pNS2PTrcbadA shows less biofilm with more visible scaffolds
(white arrow). In contrast, B. henselae Houston-1 ΔbadA mirrors the sparsity of the aggregation in
biofilm production. The ΔbadA strain shows weak biofilm production (red arrow) and visible
single rod-shaped cells (yellow arrow) on the surface of the scaffold.
Fluorescent stains were used to identify the components of a B. henselae biofilm. WGA
fluorescein is an extensively used lectin which binds N-acetylglucosamine and sialic acid residues
to emit green fluorescence. Hoechst is a nucleic acid stain which emits blue fluorescence when
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bound to A-T rich regions of DNA and Sypro-ruby is a ruthenium-based fluorescent dye which
emits red fluorescence when it interacts with essential amino acids like lysine, and histidine [189].
All three stains demonstrate that the B. henselae biofilm is made up of e-DNA, protein, and
polysaccharides (Fig 2.5a). As e-DNA and protein would be sensitive to DNase and proteinase K
cleavage, cells were treated either during inoculation, or 24 hours post-inoculation. Treatment with
either proteinase k or DNase markedly reduced the biofilm (Fig 2.5b). Both treatments at the time
of inoculation did not completely inhibit biofilm formation, but biofilm formation was reduced to
less than 50%. Maturing biofilms (24 hours) were more resistant to the application of the
proteolytic enzyme. We did not expect to observe a complete dispersal because protein interactions
with exopolysaccharides and nucleic acid components are involved in a biofilm matrix. Hence we
predicted that while proteinase K and DNase will induce an increased inhibitory effect, it would
not result in the complete dispersal of the biofilm. The sensitivity of the biofilm to both enzymes
confirms the presence of proteinaceous components and extracellular DNA.
We examined the effects of environmental conditions on a B. henselae Houston-1 biofilm
formation. One of the main differences between the arthropod vector of B. henselae, C. felis, and
the mammalian host is temperature. B. henselae must adapt to the lower temperature while
inhabiting the C. felis vector and rapidly adjust to the higher temperature of the vertebrate host
such as cats and humans. To emulate the temperature of fleas in the environment, B. henselae was
grown at 27°C; a representative temperature reported to model an environment for adult flea
activity [190, 191]. It has been speculated that bacterial persistence and colonization in the flea
gut is temperature dependent [191]. The effect of temperature on badA/BadA expression and
biofilm formation in B. henselae was examined (Fig. 2.6). While there is no statistical difference
between cell adhesion and biofilm formation under different temperatures, B. henselae grown at
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27°C rapidly forms a biofilm in comparison to B. henselae grown at 37°C (Fig 2.6a). However, at
a temperature consistent with the mammalian host, B. henselae cells within the biofilm are more
viable when compared to lower temperatures growth (Fig. 2.6b). Perhaps, bacterial persistence at
the 27°C temperature is reduced as observed by Schotthoefer et al. [191]. To confirm if bacteria
are unable to persist at 27°C because of differential gene expression, we looked at the expression
of badA at the lower temperature (Fig 2.6c). Previous studies with other bacteria have shown that
expression of some surface proteins is dependent on temperature with lower temperatures resulting
in less adhesin expression [192]. badA was not efficiently expressed at 27°C when compared to
the high expression rate at 37°C (Fig 2.6c), perhaps the reduced rate of badA expression and
adhesion is correlated to the low cell viability observed in Fig 2.6b. Different outer membrane
proteins like the filamentous hemagglutinin (Fha) with eight gene copies may compensate for the
diminished role of BadA at 27°C. In conditions consistent with mammals, B. henselae transcribes
badA efficiently within the first few days of growth as adhesion is needed for optimal aggregation.
Then badA transcription slows down once the biofilm is assembled (Fig 2.6c). At this stage of
biofilm development, polysaccharides are produced for the assembly of the extracellular matrix
whereas less BadA and other surface adhesins will be needed to aggregate cells within the biofilm
(cohesive force). Differential gene expression has been observed within other bacterial biofilms
where the production of surface appendages like flagella has been reported to be reduced in sessile
species with an increase in surface proteins used for transportation and excretion of extracellular
products [193].
Data from Fig. 2.7a shows that a slightly basic pH (pH 7.2) favors bacterial growth, and
badA transcription (Fig 2.7b). Excretion of polysaccharides, one of the components of biofilm
EPS, is sensitive to pH [194]. An alkaline environment favors biofilm development as seen in
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Fig.2.7c. The pH of growth media when a biofilm is being formed is slightly alkaline (pH 7.5).
After the biofilm is formed, we observed a decline in media pH for BadA expressing cells possibly
due to the metabolism of amino acids in Schneiders media. It is interesting to note that B. henselae
Houston-1 ΔbadA maintains an alkaline pH throughout the entire growth period (Fig 2.7c). B.
henselae has been shown to catabolize amino acids through the TCA cycle releasing CO2 which
will contribute to an acidic pH. The TCA cycle releases carbon to generate ATP used to provide
the energy needed for a variety of downstream effects like activation of response regulators in a
two-component system. It is possible a change in metabolome products characterize the pH of the
biofilm media. In Pseudomonas fluorescens, planktonic metabolism was characterized by a change
in metabolome products whereas the biofilm bacteria exhibited exopolysaccharide metabolism
[195].
In conclusion, BadA is required for optimal biofilm formation; it plays a significant role in
B. henselae persistence and infection hence, it is likely that B. henselae uses BadA as an adhesin
to attach itself to a wide range of host cells and extracellular matrix proteins. There, the bacteria
form biofilms comprised of polysaccharides, protein, and e-DNA that help the bacteria prevent
phagocytosis and contribute to the persistence. We propose that B. henselae cells are disseminated
from the biofilm to circulate in the bloodstream to continue to spread infection, explaining the
enigma of persistent or relapsing bacteremia in patients infected with B. henselae. BadA plays a
critical role in this process as we have shown in this report and as observed in patients with
infective endocarditis caused by B. henselae [5].
Finally, we present evidence that a higher temperature and slightly basic pH consistent with
the mammalian host are optimal for growth, adhesion, and badA expression. Since badA is not
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expressed efficiently at lower temperatures consistent with adult fleas in the environment, we
propose that other outer membrane proteins may be expressed in vivo in the flea.
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Chapter 3: Elucidating the role of the 3' end of Brt1
3.1.

Background
Gene regulation by transcription termination-antitermination often referred to as

transcription attenuation, is a strategy commonly used by bacteria to sense specific environmental
or metabolic signals and allows RNA polymerase to respond by either terminating transcription or
transcribing the downstream genes of an operon [196].
Stem-loops, also called hairpins are base pairing patterns that occur when two regions of
the same strand complement each other and base pair to form a double helix with an unpaired loop
region. Computer-based analyses are used to search for possible alternative RNA-hairpin
structures in the leader sequence preceding a specific gene or operon to predict transcription
attenuators [197]. In RNAs, stem-loops can direct RNA folding, protect the messenger RNA
(mRNA) structural stability, provide RNA binding protein recognition sites and serve as a
substratum for enzymatic reactions [198]. Stem-loops are used to terminate transcription in
prokaryotes using a rho-independent transcription mechanism; a process where stem-loop forms
on an mRNA strand, dissociating the RNA polymerase from the DNA template strand [199]. Rhoindependent termination is frequently used by riboswitches.
Riboswitches are cis-acting RNA regulatory elements that respond to small molecule
metabolites concentration or to environmental changes like pH and temperature (RNA
thermometers) to affect gene expression levels. They were first described as transcription
attenuators because changes in transcript level affected transcript elongation by the formation of a
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terminating/anti-terminating structure. Riboswitches have been shown to regulate gene expression
by using Rho-independent termination [200], sequestering the ribosome binding site (RBS) [201],
as a ribozyme that cleaves itself in the presence of a metabolite [202], regulating adjacent genes
[203], or responding to temperature by melting the stem-loop to allow transcription of a
downstream gene [204]. Riboswitches generally consist of two parts: the aptamer region that binds
the ligand and the expression platform that adopts the conformational RNA structure change
regulating gene expression.
The RNA thermometer is another method of regulating the expression of a downstream
gene. Temperature-dependent stem-loops/hairpins structures form in the mRNA preventing
transcription. Most thermometers form stem-loops which sequester the ribosome binding site
sequence. Very few signal transduction systems that respond to sudden changes in temperature
can detect actual changes [205], most measure the effects of temperature-induced damage (heat
shock) rather than temperature [206]. RNATs, on the other hand, respond immediately to control
the already existing mRNA translation [160].
As previously discussed, the Brt RNAs all have a stem-loop at the 3' end (Fig 1.1a) with
very low Gibbs free energy that is considered the most favored stable structure. The brts are highly
conserved especially around the 3' region (Fig 1.1b) and are highly transcribed under the conditions
of the RNA-seq (Fig 1.1c) [128]. However, the trps found downstream of each brt were minimally
transcribed. The high brt transcription ends just before the coding region of the downstream trp
gene. Also, the region between the tentative end of the RNA and the beginning of each trp harbors
approximately 15 nucleotides eliminating the probability of a native trp promoter (Fig 1.2b).
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Using the rationale that the most expressed Brt, Brt1, may have the most impact on
phenotype, we used the first pair of this multicopy gene family, brt1/trp1 to study the role of the
3' end of the Brt1 as a transcript terminator preventing transcription of the downstream trp1.
3.2. Materials and Methods.
3.2.1. Bacterial Strains
E.coli strain DH5α, DH12s, B. henselae Houston-1/pNSbrt1-GFP, B. henselae Houston1/pNS2brt1Δ3'-GFP, B. henselae Houston-1/pNS2-GFP and B. henselae Houston-1brt1Δ3' were
all used for this study (Table 3.1). E.coli DH5α and DH12s cell were grown at 37°C on either LB
agar or liquid LB broth. B. henselae is grown as previously described. All B. henselae Houston-1GFP constructs were grown on chocolate agar supplemented with kanamycin (50µg/ml). B.
henselae Houston-1brt1Δ3' were grown on chocolate agar.

Table 3.1. Bacterial strains and primers used for aim 3

Primer/plasmid

Sequence/purpose

Brt1 prom f

GCAGGTCGACATAACTTTCACAGACGAAAACGG

Brt1 prom R

GCACGGATCCCGACTTGCTTTTAGTG

Brt1 term R

GCACGGATCCTGATGCTTCTTCTGAAGCGA

GFP for

TGGCGGATCCGAGGAGAATTAAGCATGCG

GFP rev

TGGCTCTAGAGAGGAGAATTAAGCATGCG

Brt1 3' F1

GCAGGGATCCTAGCGATAAAC
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Table 3.1 (continued).

Primer/plasmid

Sequence/purpose

Brt1 3' R1

AGACCCCGGAATACCAACG

Brt1 3' F2

CGTTGGTATTCCGGGGTCTGTGGGGAATCTTTCAAA

Brt1 3' R2

TCTAGAGGATCCCTTGCCCTCTG

Brt1 F

TAGGGCCTGGAAGCTCTAAC

Brt1 R

GTCTGGAAGCACTGACTACG

B. henselae Houston1/pNS2-GFP

To control for transcription of GFP without a promoter

B. henselae Houston1/pNS2PTrcbrt1-GFP

To assess transcription of GFP using a native brt1 promoter
and gene

B. henselae Houston1/pNS2PTrcbrt1Δ3'-GFP

To assess transcription of GFP using a native brt1 promoter
and the brt1 gene without the 3' end of the Brt1.

Restriction sites are italicized.

3.2.2. Construction of B. henselae Houston-1-GFP strains.
3.2.2.1. Construction of B. henselae Houston-1/pNS2 gfp mut 3
A 751nt gfp product was codon-optimized for B. henselae and commercially
synthesized by Gene Universal in a pJET plasmid. The gfp was amplified using gfp for and rev
primers (table 3.1). The PCR product was cleaned up (NEB T1030s), digested with BamHI and
Xbal enzymes (NEB RO136S, RO145S), and gel purified (NEB T1020s). The purified GFP
amplicon was ligated into the pNS2 plasmid using the BamHI and Xbal sites. The plasmids were
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transformed into competent DH5α E.coli cells and the resulting colonies selected using 50µg/ml
kanamycin. Colonies are grown in 5ml of LB media supplemented with kanamycin; plasmid was
extracted using a miniprep kit (Promega A1460) and sequence confirmed by Genewiz Universal.
The plasmid was electroporated into B. henselae Houston-1 using the protocol described by RestoRuiz et al. 2000 [207] to produce B. henselae Houston-1 pNS2- gfp mut 3 (Fig 3.1a, Table 3.1).
3.2.2.2. Construction of B. henselae Houston-1/pNS2 brt1Δ3'- gfp mut 3
A 471nt PCR product bearing the Brt1 promoter and 145/196nt of the full-length
brt1 was amplified using Brt1 prom for and Brt1 prom rev primers (Table 3.1). The product was
processed (purified, digested and gel extracted as described above) and ligated in-frame into the
pNS2-PTrc plasmid using the Sall and BamHI sites to remove the Trc promoter. The plasmid was
transformed and selected as described above. Positive colonies were grown in 5ml of LB media
supplemented with kanamycin; plasmid is extracted using and sequence confirmed. Positive
plasmids were electroporated into B. henselae Houston-as described above to produce B. henselae
Houston-1 pNS2-Brt1 promoter-brt1 Δ3'-gfp (Fig 3.1a, Table 3.1).
3.2.2.3. Construction of B. henselae Houston-1/pNS2 brt1- gfp mut 3
In order to generate B. henselae Houston-1/pNS2 brt1-GFP, a 609nt PCR product
bearing the brt1 promoter and 196/196nt of the full-length brt1 and the intergenic region between
brt1 and trp1 was amplified using Brt1 prom for and Brt 1 term rev primers (Table 3.1). The
product was processed as described above and ligated in-frame into the pNS2-PTrc plasmid using
the Sall and BamHI sites. The plasmids were transformed, selected, sequence confirmed and
electroporated as described above to produce B. henselae Houston-1 pNS2-Brt1 promoter-brt1gfp (Fig 3.1a). All three GFP expressing strains were used for growth rates to determine differences
in growth pattern if any (Fig 3.1b)
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Fig 3.1: Growth of B. henselae brt1-GFP constructs. A. Diagram of the different constructs of brt-gfp in B. henselae. B. Growth
curve experiment using all three Bh-GFP expressing strains.

3.2.3. Fluorescence microscopy
Using CLSM imaging, we monitored GFP expression in B. henselae GFP strains, 10^6
bacteria cells in a 200µl volume were seeded into 8-well chamber slides and grown overnight at
37°C and 5% CO2. Samples were examined next day at 10x magnification using an Olympus
Fluoview FV1000 microscope. Images were exported as TIFF.
3.2.4. Flow Cytometry
B. henselae GFP cells were seeded into a 50ml flask (100,000 cells/flask) for 48 hours.
Cells are collected by gently scraping and washed with PBS. Flow cytometry analysis was
performed with BD FacsCanto II flow cytometer using the 530/30nm detector with laser emitted
at a fixed wavelength of 488nm. A minimum total of 50,000 gated events were collected for all
three samples. Instrument setting was kept the same for all samples and independent experiment.
Flow cytometry analysis was performed three times using a cutoff of 50,000 cells. Data were
analyzed using Facs Diva 6.3.1 software and graphs were made with Sigma plot.
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3.2.5. Construction of B. henselae Houston-1 Brt1Δ3'
A deletion mutant of the 3' end of brt1 in B. henselae Houston-1 using the two-step
mutagenesis strategy described by Mackichan et al. (2008) was constructed with certain
modifications. [208]. To generate two fragments of the gene, B. henselae genomic DNA was used
as a template for PCR. Primer pair Brt1 3' F1 and R1 was used to amplify the first fragment
containing the promoter region and the brt1 gene without the 3' loop. The second fragment
containing the 15 nucleotides intergenic region between brt1 and trp1 and the complete trp1 gene
was amplified using primer pair Brt1 3' F2 and R2. The two purified PCR products were used as
templates for mega prime PCR using only the primers Brt1 3' F1 and R2. The resulting product
was ligated into the “suicide” plasmid pJM05 at the BamHI restriction site, transformed in E.coli
DH12S, verified by plasmid sequencing and then incorporated into B. henselae Houston-1 by
transconjugation. Transconjugants were selected by plating on Heart Infusion agar with
supplemented with kanamycin (30 μg/mL). Colonies were counter-selected on agar containing
10% sucrose to select for a second cross-over event, resulting in the full-length gene being replaced
with the truncated version producing B. henselae Houston-1 Brt1Δ3' (Fig 3.3a). The deletion
mutant was confirmed by PCR and RT-PCR to ensure the absence of the full-length brt1.
3.2.6. Biofilm formation in B. henselae Houston-1 Brt1Δ3'
Biofilm was monitored using methods described in Aim 2.2.4. Cells were seeded onto the
plates, and real-time measurement occurred every 15 mins over 72 hours. Data was exported as an
excel sheet, and Sigmaplot was used for graph and data analysis.
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3.2.7. brt1, trp1, and badA expression in B. henselae Houston-1 Brt1Δ3'
To examine the expression of badA, brt1, and trp1 in a B. henselae Houston-1 Brt1Δ3'
culture, cells were cultured on chocolate agar plates at 37°C, 5% CO2 for 3 days. The method
described in aim 2.3.3 was used. Briefly, bacteria were collected, gently washed with PBS and
RNA extracted with the trizol reagent. 10µg of the resulting RNA was treated with Turbo DNase
and 1µg reverse transcribed to cDNA. RT‐qPCR was performed in a total volume of 25 μl as
previously described using primers badA screen 1F and 1R (Table 2.1), trp1 f and r (Table 3.1),
brt1 F and R (Table 3.1). The 50S ribosomal protein L4 (rpld primer f and R: table 2.1), was used
as the reference gene for normalization. The reaction conditions are as previously described.
3.3. Results
3.3.1. The 3'end of Brt1 acts as a transcriptional attenuator.
Expression of GFP under the control of a full-length or truncated Brt1 was monitored using
both fluorescence microscopy and flow cytometry. All transformants showed differential gene
expression level. The fluorescence of the GFP expressing B. henselae Houston-1 pNS2/brt1 Δ3’gfp was stronger for both microscopy (Fig 3.2a) and flow cytometry (Fig 3.2b) in comparison to
the fluorescence observed from the control B. henselae Houston-1 pNS2–gfp or the B. henselae
Houston-1 pNS2/brt1-gfp. In the absence of the 3' terminating loop, GFP expression using a flow
cytometer was at least 30 times more intense than the Houston-1 pNS2-gfp or the B. henselae
Houston-1 pNS2/brt1-gfp (Fig 3.2b, P= 0.008). Both Houston-1/pNS2-gfp and the B. henselae
Houston-1 pNS2/brt1-gfp exhibited low GFP fluorescence that did not differ statistically (P=
0.119). The presence or absence of the 3' region did not impact growth as growth rate with all three
strains resulted in similar curves (Fig 3.1b).
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Fig 3.2: Comparison of GFP intensity in Brt1-GFP constructs. A. Confocal microscopy showing B. henselae Houston-1/pNS2-gfp,
B. henselae Houston-1/pNS2-brt1-gfp, B. henselae Houston-1/pNS2-brt1Δ3'-gfp using confocal microscopy. B. Comparison of
GFP intensity in B. henselae Houston-1/pNS2-gfp, B. henselae Houston-1/pNS2-brt1-gfp, B. henselae Houston-1/pNS2-brt1Δ3'gfp using flow cytometry. Bars represent the average of three independent experiments. Error bars represent standard error of the
mean. (Students t-test, * = P = 0.008, ** = P = 0.119).
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3.3.2. Biofilm formation increases in B. henselae Houston-1 brt1Δ3'
To assess the ability of B. henselae Houston-1/brt1Δ3' to form biofilms, the xCelligence
RTCA method applied in aim 2.2.4 was used. Fig 3.3c shows the effect of the 3' terminating loop
on biofilm formation. The absence of the loop significantly affected adhesion and biofilm
formation in B. henselae Houston-1/brt1Δ3'. We observed that in the absence of this loop, the
adherent period for B. henselae Houston-1/brt1Δ3' was faster and quicker in comparison to the
time it takes the wildtype B. henselae Houston-1 to adhere (Fig 3.3c, magnified circle). The biofilm
formed between the two strains was significantly different (P = ˂0.001, Mann-Whitney U
Statistic). Fluorescent microscopy was used to evaluate the viability of cells within each biofilm
(Fig 3.4a) and we observed that after 48 hours, the cells within the biofilm are less viable when
compared to the Houston-1 cells.
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Fig 3.3: Growth and biofilm analysis of B. henselae Houston-1/brt1Δ3‘. A. Construction of B. henselae Houston-1/brt1Δ3‘. B.
Growth curve of Houston-1 vs. Houston-1/brt1Δ3‘. C. Biofilm formation of Houston-1 vs. Houston-1/brt1Δ3‘.

3.3.3. brt1, trp1, and badA expression in B. henselae Houston-1 brt1Δ3'
Figure 3.4b shows that in the absence of the 3' end of Brt1, both trp1 and badA transcription
rates are upregulated in comparison to the B. henselae Houston-1. brt1 is still detected in B.
henselae Houston-1/brt1Δ3' signifying that the gene is still being transcribed. Since growth curves
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between the two strains did not differ (Fig 3.3b), the changes in gene expression was not a factor
of growth. The absence of the 3’ stem-loop affected the transcription of the downstream gene, trp1
and also upregulated badA expression.

Fig. 3.4. Cell viability and gene expression levels in B. henselae Houston-1/brt1Δ3'. A. CLSM image of B. henselae Houston-1
and B. henselae Houston-1/brt1Δ3 biofilm populations using the STYO9/PI live/dead staining. B. Gene expression level in B.
henselae Houston-1/brt1Δ3' biofilm show significant upregulation of trp1 and badA (P = 0.001). There was no significant
difference in brt1 expression (** = P = 0.115).

3.4. Conclusion
Genetic adaptation is the cornerstone of fitness and survival, and flexibility in controlling
gene expression permits the bacteria to rapidly express genes required for survival. Regulatory
regions may be present in the 5′ UTR of the mRNA (e.g., riboswitches, thermosensors, and pH
sensors) that they regulate.
The Brts are ncRNAs that are highly expressed in the genome of B. henselae. The Brts was
the 4th highest genome reads by the RNA-seq analysis [157]. Indeed, the Brts have been
characterized as being “located in a plastic, repeat-rich genome region leading to strong
transcription of genes that do not represent a bona fide protein-coding ORF” (Fig 1.2a) [157]. This
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characteristic signifies horizontal gene acquisition. Horizontal gene transfer allows bacteria to
acquire and express genes which respond quickly and adapt to a stressed environment promoting
bacteria survival and fitness in a new environment.
Bioinformatic analysis using NCBI BLAST show that the Brts have a high degree of
homology and are specific to the Bartonella species only. The number of RNAs varied between
species with the human-specific species bearing 0- 2 copies [128]. It is, therefore, possible that B.
henselae acquired and duplicated the new region of high repeats to help adapt to new mammalian
hosts.
RNA-Seq shows that although the Brts are highly transcribed, the downstream trp genes
are poorly transcribed [128]. The distance between the tentative end of the brts and the start codon
of the trps is approximately 15nt (Fig 1.2b and Fig 3.3a). The arrangement suggests that the cisacting element in the 3' end of the Brt1 controls transcription of the downstream trp1. Using the
neural network for promoter prediction program [209], we were unable to find a putative promoter
within the 15 nucleotides intergenic region between brt1 and trp1 or an open reading frame on the
Brt1 RNA. Using ARNold [210], Brt1 is predicted to form a rho-independent stem and loop
structure. Perhaps this terminating region is responsible for pre-mature trp transcription. To
confirm this hypothesis, the trp1 gene was replaced with the gfp gene. The brt1 promoter and a
full-length or truncated brt1 was used to drive the transcription of gfp using a promoterless plasmid
with gfp to serve as a control (Fig 3.1a). To determine if the 3' loop acts as a terminator, a portion
of the brt1 bearing a native promoter but without a terminating loop structure was cloned upstream
of the gfp gene (Fig 3.1a) and GFP expression in the absence of the 3' end was quantified. All
strains were analyzed for growth defect. Fig 3.1b shows that all three strains have no significant
difference in growth rate. The bacteria clones were grown on a 6 well plate for 24 hours and
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imaged. We observed that in the absence of the 3'end of Brt1, there is GFP transcription and
translation which is otherwise absent in the full-length Brt1 (Fig 3.2a) . We used a flow cytometer
to quantify the intensity of the GFP expression and observed an upregulated GFP expression in
comparison to the full-length Brt1 and the promoterless GFP plasmid. Deletion of the 3' loop
clearly resulted in higher GFP expression (Fig 3.2).
To confirm the effect of this stem-loop on the native trp1 and biofilm formation, the 3' end
of the Brt1 in the B. henselae Houston-1 was deleted to generate B. henselae Houston-1 brt1Δ3'
(Fig 3.3a). Biofilm data indicates that the Δ3' mutant shows a significant increase in time for
adherence, and for biofilm formation in comparison to the B. henselae Houston-1 (Fig 3.3c). The
growth curves for both strains did not show a significant difference (Fig 3.3b), hence the difference
in both aggregation and biofilm formation was not a factor of growth. The confocal analysis using
the live/dead stain previously described shows that cells in the biofilms have a significant
difference in cell viability (Fig 3.4a). Cells in the B. henselae Houston-1 brt1Δ3' biofilm were less
viable as signified by the increased presence of PI. Previously in Chapter two, the absence of badA
was speculated to affect cell metabolism. Bacteria cells regulate checkpoint(s) which control cell
growth and replication rates in a biofilm by using quorum sensing. It is also possible that deleting
the terminating loop affects a checkpoint ultimately leading to badA overexpression and nutrient
exhaustion.
Clearly, the data presented here confirm that Brt1 acts as a transcription terminator for trp1.
We speculate that one of the major differences between the arthropod vector and the mammalian
host (outlined in table 1.1) may be responsible for the formation of this terminating loop. Further
experiments will be carried out to determine if any of the environmental factor(s) is/are responsible
for the activation/deactivation of the loop.
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Chapter 4: Role of Trp1 in biofilm regulation
4.1. Background
Prokaryotic cell regulation must be highly responsive to dramatic environmental changes
to enable bacteria to adapt. Stress signals activate or repress genes controlling the expression of
genes that are best suited for the fitness of the cell in the current environment. The most critical
control point for gene expression is transcriptional initiation. It is regulated by a combination of
factors, including the sequence of DNA and structure that permits promoter recognition,
transcription factors, and small molecules [211]. Transcriptional factors (TF)/transcriptional
regulators/DNA binding proteins are proteins that bind specific sequences upstream of their target
genes and are involved in gene regulation by activating or repressing gene expression [212]. TFs
must contain at least one DNA binding domain. Three recurrent DNA-binding motifs have been
described: the helix-turn-helix (HTH), the winged-helix (WH) and the β ribbon [213, 214]. The
HTH motif is the most widely used DNA - binding motif in prokaryotes. It consists of two helices,
packed at angles of approximately 120°, together with a tight four - residue turn with glycine
usually found in the second position. The HTH motif alone is not enough for independent folding,
and a third α helix stabilizes the motif as a compact, globular domain. The second helix in the HTH
motif is called the 'recognition helix' because it is inserted into the major groove of the DNA and
is critical to nucleotide specificity. Most TFs are identified by the presence of a DNA binding
domain using sequence searches against protein family databases like NCBI-BLAST [215] and
PFam [216].
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XREs (xenobiotic response elements) are a family of TFs and the second most frequently
occurring regulator family in bacteria that control various and diverse metabolic functions [217].
The XRE family of transcriptional regulators are a large family of proteins with a DNA -binding
helix-turn-helix motif similar to the SinR protein in Bacillus subtilis [218]. XRE-family regulators
share an exclusive N-terminal HTH DNA binding domain, while the C-terminal regulatory region
is highly variable [219]. In the literature, HTH XRE has been shown to serve as a switch between
bacteria motility, adhesion [220], and biofilm formation [173, 176]. Most prokaryotic TFs are
homodimers that bind to DNA sites that are palindromic or pseudo palindromic often called DNA
recognition sequences, regulatory elements or transcription factor binding sites (TFBS) [221, 222].
TFs may work alone or with other proteins in a complex to promote (activate) or block
(repress) recruitment of RNAP ultimately affecting gene transcription. In the presence of a
repressor, TF is inactive but become activated once the repressor is dissociated from target DNA
after association with an inducer [223]. On the other hand, transcription factors known as positive
regulators or activators, require interaction with effector ligands to function. Repressors and
activators are interconvertible depending on the DNA binding position of the promoters [223].
Prokaryotic transcription factors can detect changes in extracellular environmental conditions
and/or intracellular metabolic states. Some genes are regulated by 2 or more transcription factors
with each transcription factor expressed under different conditions as observed in the stress
response genes of E.coli, biofilm and planktonic states of cells [224-226]. Hence in a biofilm,
expression rates of TFs will fluctuate depending on their regulatory target(s).
Advances in molecular genetics have shown that while unusual, bacterial genomes may
harbor multiple copies of their genes [227]. By remodeling their genomes, bacteria adapt to new
environmental niches. Genome sequencing has revealed a prominent role for gene gain and loss in
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niche adaptation, specialization, host switching, and other changes in lifestyle. [228]. Multicopy
genes are common on the bacterial chromosomes and while no phenotype has been consistently
associated with multicopy genes, multi copies of rRNA have been linked to high growth rates
[229].
The multicopy trp genes are annotated as genes which code for transcriptional regulators.
They encode the distinguishing HTH-XRE factor. Under the conditions for the RNA seq carried
out by Tu et al. (2016) [128], the trps were minimally transcribed. Overexpression of the trp1 gene
shows that trp1 is a positive regulator of badA [128].
To confirm the relationship between the badA and Trp1, we employed the use of
bioinformatics, electrophoretic mobility shift assay (EMSA) and a tagged DNA pull-down
accompanied by mass spectrometry. We used both BioPHP [230] and EMBOSS [231] to screen
for the presence of a palindrome or an inverted repeat in the badA promoter region. EMSA is a
rapid, sensitive, qualitative method used to detect protein-nucleic acid interactions [232, 233]. In
the assay, the protein and the DNA components are combined in vitro, and the resulting mixture
is subjected to non-denaturing electrophoresis. The mobility of a protein-nucleic acid complex is
typically less than that of the free nucleic acid. The DNA pulldown product is subjected to
electrophoresis and mass spectrometry (MS) to identify other proteins isolated by a DNA pulldown strategy from a Houston-1 lysate using a biotinylated badA promoter region.
In this chapter, I hypothesize that one or more of the Trps are the TFs, activators, and/or
repressors responsible for regulating the transcription of badA.
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4.2. Materials and Methods
Table 4.1. Bacterial strains and primers used for aim 4.

Plasmid/primer

Sequence/purpose

badA Promoter F

AGTACACAACAAAAACAGCC

5' Biotin-badA Promoter R

(Biotin) GTCTCTTTGATGTGACAG

badA Promoter R

GTCTCTTTGATGTGACAG

badA coding region F

ACGCATGTAGAGAATGGTGA

badA coding region R

CTTCGCATCTTCAAGCACTATCT

5’ biotin-badA coding region R

(Biotin) CTTCGCATCTTCAAGCACTATCT

Solu E.coli

Expression of His-tagged Trp1

4.2.1. Construction and purification of SoluBL21/pET28a Trp1
The trp1 gene, codon-optimized for B. henselae, was cloned into pET28a plasmid using
the Ndel, and Xhol restriction sites and a 6x‐His affinity tag appended to the N terminus. The
plasmid was transformed into SoluBL21 competent E.coli (Amsbio, C700200). Positive clones
were selected with 50ug/ml kanamycin and confirmed by PCR. Solu BL21 cells were grown in
LB media until OD reached 0.4 (OD600nm). Cells were induced with 0.5mM IPTG for 3 hours at
27°C, pelleted and lysed with a cocktail of B-per lysis buffer (ThermoSci, 89821), a protease
inhibitor, KCl, and lysosome. The 6xHis-tagged Trp1 was purified using Ni‐NTA affinity spin
column (ThermoSci, 88225) according to the manufacturer’s protocol. Protein was concentrated
and desalted with a protein concentrator (Thermo Scientific™ Pierce™ PES, 88513) and sample
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purity checked with a 4-12% Bis-Tris gel (Invitrogen, NP0332Box) stained with Coomassie. A
western blot was also performed using an anti-his tag primary antibody to confirm the presence of
the tagged protein. Protein concentration was calculated using OD280nm.
4.2.2. Biotinylation, amplification, and purification of the badA promoter region.
A 342bp region consisting of the badA promoter and coding region was amplified using
primers badA Promoter F and biotin-badA promoter R (Table 4.1) bearing a standard biotin tag on
3'end. The amplicon was cleaned up (NEB T1030s), gel extracted on a 0.7% agarose gel and
purified (NEB T1020s). The unlabeled promoter region used as a control was made with the same
primer set without a biotin tag (badA Promoter R: Table 4.1). Our negative control, a 350bp of the
3' coding region of badA was made using the primer set badA coding region F and R (Table 4.1).
All amplicons were run on a 0.7% agarose gel to purify and confirm the absence of primer dimers
or contaminating band(s).
4.2.3. Electrophoretic Mobility Shift Assay (EMSA)
20fmol (1nM) of biotin-labeled badA promoter region, 200pmol (10µM) of Trp1 protein,
1x binding buffer, 2.5% glycerol, 5mm MgCl2, 0.05% Np-40, and 50ng/µl of Poly-IDC
(ThermoFisherSci., 20148) was mixed in a total volume of 20µl and incubated for 30 mins at 37°C.
200nM of non-biotin badA promoter region was used as a competitive inhibitor. 5µl of 5x loading
buffer was added, and the reaction was resolved by electrophoresis using a 6% DNA retardation
gel (Invitrogen, EC6365) in 0.5x TBE buffer. The gel was transferred at 380mA for 50 mins onto
a nylon membrane (ThermoFisherSci. Biodyne™ B Nylon Membrane, 0.45 µm, No 77016) using
cooled 0.5x TBE buffer in a circulating water bath. The membrane was cross-linked at 120mJ/cm2
with the Stratagene UV strata linker (auto crosslink function). The membrane was blocked,
washed, equilibrated and exposed according to the manufacturer’s protocol. Bio-rad chemidoc
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XRS imaging system was used to detect bands and images exported as TIFF. EMSA experiments
were repeated three times independently to confirm reproducibility.
4.2.4. RT-qPCR of trp1 and badA in a biofilm community.
Using primer pairs badA screen 1F and 1R (Table 2.1) and trp1 F and R (Table 3.1), the
expression levels of trp1 and badA in a biofilm was analyzed and compared to bacteria grown in
the planktonic state. The bacteria were grown in a 6-well plate for 48 hours, washed gently, and
trizol reagent added directly to the biofilm at the bottom of the plate. To mimic planktonic growth,
the 6 well plate containing the samples were incubated on a rocker with mild agitation (100rpm) to
prevent adhesion. Sample processing and RT-qPCR experiment were performed as described in
Aim 3.2.6.
4.2.5. badA promoter region pulldown.
To identify all proteins which may act as activators or inhibitors of badA transcription, the
biotinylated badA promoter region from aim 4.2.2 above was used to perform an in vitro pulldown
assay. B. henselae Houston-1 cells were grown as a biofilm in a 50ml flask. The supernatant was
removed and adherent cells at the bottom of the flask were lysed using a non-denaturing cell lysis
buffer (ThermoSci. 89821) with protease inhibitor. The cells debris was pelleted for 5 mins at
14,000xg, and the lysate supernatant was incubated overnight with the biotinylated DNA at 4°C.
The sample was incubated with streptavidin beads at room temperature for an hour, washed
according to the manufacturer’s protocol and eluted in 60ul of the elution buffer present in the kit.
The sample was spun to dry in a vacuum, reconstituted using ultrapure mass spectrometry grade
water and analyzed using an LC/MS. Data were analyzed using Proteomics discover (ThermoSci)
and SEQUEST [234]. Products were sorted based on peptide-spectrum matches (PSM) and
confidence intervals (0.01 for high and 0.05 for medium).
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4.3.

Results
4.3.1. Trp1 binds badA promoter region to activate gene transcription.
EMSA was carried out to determine the role of the Trp1 protein as a transcriptional factor

for badA. The data shows that the purified Trp1 protein binds the 342bp containing the putative
promoter region of badA gene (Fig 4.1). A substantial shift in the control DNA band was observed
when incubated with the recombinant Trp1 protein. This band shift is suppressed in the presence
of a 200-fold excess unlabeled DNA which acts as a competitive inhibitor. To further confirm the
specificity of the Trp1 to the putative promoter region, a negative control which consists of badA
coding region (3' end of the badA gene) was added to Trp1 alongside the biotin-tagged promoter
region and no band displacement was observed. This result suggests that the Trp1 regulates the
transcription of badA gene through direct, specific interaction with the badA promoter region.

Fig 4.1. EMSA image of Trp1 and badA putative promoter region. EMSA image confirming that Trp1 binds the promoter region of
badA to turn on gene transcription.
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4.3.2. trp1 and badA are upregulated in a biofilm community
RT-qPCR using badA and trp1 specific primers was used to access transcription levels
between growth methods. The data shows that both genes are significantly upregulated in a biofilm
community when compared to bacteria grown to mimic planktonic growth (Fig 4.2a). Likewise
looking at the transcription rate of trp1 and badA in a B. henselae Houston-1 biofilm, we observe
that both genes are significantly upregulated to coincide with the first step of biofilm formationadhesion on day 1. As the number of days increases, we observe that the transcription rate of both
genes reduces as the biofilm is being formed (Fig 4.2b). This data confirms that both trp1 and
badA are needed for optimal biofilm formation.

Fig 4.2. Gene expression levels in a biofilm. A. Comparison of trp1 and badA expression levels in a biofilm. B. Expression levels
of trp1 and badA overtime in a B. henselae Houston-1 biofilm. RT-qPCR bars represent the average of 6 replicates and error bars
represent the SEM. (P ≤ 0.001 for both Fig 4.2a and b).

4.3.3. Trp3, amongst other genes, also binds the badA promoter region.
To determine whether badA is capable of being bound and regulated by any other DNA
binding protein, we employed the use of streptavidin pulldown coupled with mass spectrometry.
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Data shows that Trp1 is not the only protein which interacts with badA promoter. Using the PSM
and a medium confidence interval cutoff, it was noted that 5 other proteins (Table 4.2) not
including Trp1 are able to bind the promoter region of badA to regulate expression. Trp3, a HTHXRE-DNA binding protein and member of the Trp family is also able to bind the badA promoter
region. The other proteins identified could associate either by direct binding or through proteinprotein interaction as in the case of ClpB which is known to help with protein folding/refolding.

Table 4.2. Proteins that bind to the badA promoter region.

Accession
number

Description

Locus number

PSM

A0A0H3LWB5

Hypothetical prophage protein

BH03140

111

A0A0H3LWT1

Transcription-repair-coupling factor

BH08750

111

A0A0H3LXU6

Chaperone protein ClpB

BH14110

71

A0A0H3LYA4

Transcriptional regulator (Trp3)

BH13590

22

A0A0H3LXV5

Uncharacterized protein

BH14240

19

4.4. Conclusion
As briefly mentioned in the introduction, TFs recognize palindromic or pseudo palindromic
sites on the promoters of genes they regulate. Gene expression is regulated by TFs that bind the
promoter region of a gene to activate/repress gene transcription. Many bacterial transcription
factors are dimeric proteins and their transcription factor binding site (TFBS) are generally
believed to be palindromic or symmetrical [222, 235]. Bioinformatics analysis using a 342 bp
upstream of the badA start codon shows that there are palindromic sequences upstream of the badA
start codon. To determine whether Trp1 directly binds badA promoter region, EMSA was
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employed. Fig 4.1 confirms that there is a direct interaction between the promoter region of badA
and the Trp1 TF. We observe a single lower band in lane one for the target DNA but on the addition
of Trp1, we observe an increase in band size signaling increased molecular weight from the
interaction of badA and Trp1 (Fig 4.1, lane 2). We also observe a competitive interaction with the
addition of non-biotinylated target DNA- lane 3. The intensity of the band in column two decreases
suggesting biotinylated DNA displacement which is confirmed by the increased intensity of the
lower band in lane 3. We also confirmed that this interaction is specific to the promoter region of
badA; a negative control using a coding region of the badA gene was unable to bind or compete
with badA DNA for Trp1 (lanes 5 and 6).
As confirmed by the EMSA, trp1, binds directly to badA. If the Trp1 is responsible for
activating badA transcription and BadA is responsible for the first step in biofilm formation, then
an upregulation of Trp1 will lead to upregulation in BadA and biofilm formation. Fig 4.2 shows
upregulation of trp1 and badA in a biofilm in comparison to planktonic growth. In 4.2b, we observe
a decline in gene transcription level as days increases perhaps signaling the reduced need for trp1
and badA once a biofilm is formed.
To identify other proteins which may regulate expression of badA, the biotinylated
promoter region of badA was used to perform a pull-down with cell lysate of B. henselae Houston1. The DNA-protein complex was purified using streptavidin beads. While the EMSA was used to
confirm that Trp1 binds badA promoter, the pull-down identified other activators/repressors, etc.
that may also interact with the promoter region of badA. Trp3 is a transcriptional regulator with an
HTH DNA binding site, hence it is capable of regulating a gene much like the Trp1. Much like
Trp1, the Trp3 belongs to the family of nine transcriptional HTH regulator found in B. henselae
and also harbors Brt3 upstream of the start codon. Other proteins pulled down include ClpB, an
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ATP-dependent chaperone protein and a part of the stress-induced multi-chaperone system
involved in protein metabolism and in the recovery of cells from heat-induced damage [236]. It
unfolds denatured protein aggregates and exposes new binding sites on proteins bound to it
contributing to solubilization and refolding of a denatured protein aggregate by DnaK. The
transcription-repair coupling factor (TRCF) in bacteria is a pathway for nucleotide excision repair
(NER) and is also used to dislodge inactive RNA polymerase molecules stalled on the template
DNA.
In general, we confirm that Trp1 interacts directly with the badA promoter region (Fig 4.1).
badA and trp1 transcript levels are significantly upregulated in a biofilm community especially on
the first day of biofilm formation and decreases as biofilms are formed (Fig 2.1, Fig 4.2). Our data
show that the combined approach of capturing DNA affinity and mass-spectrometric protein
sequencing identifies proteins involved in the formation of multi-component complexes on DNA
through direct interaction with specific sequence elements or conformational structures. We were
able to capture proteins which interact with badA in a biofilm community. While we are not
entirely certain as to the functions of each protein, it is particularly interesting to note that Trp3
can also bind the badA promoter region. A previous report linked Trp1 as a positive regulator
[128]. This chapter provides evidence of direct interaction between Trp1 and badA.
Results of this aim shed light on the relationship between Trp1, badA/BadA and biofilm
formation in B. henselae. We speculate that both Trp1 and Trp3 are able to bind the promoter
region of badA as positive regulators to activate gene expression. This interaction may or may not
require co-activators. Bacteria may typically duplicate genes to compensate for a copy loss. The
bacteria will transcribe and translate badA/BadA for adhesion to the surface. Once the bacteria are
firmly attached, the signal for the synthesis of polysaccharides for the production of EPS starts and
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biofilm is being formed. EPS synthesis and biofilm formation become a feedback signal to stop
transcription of badA. The repressor and/or co-repressor for badA will bind to repress badA and
trp1 genes leading to the decrease observed in figure 4.2b.
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Chapter 5: Role of Brt1 in biofilm regulation
5.1. Background.
sRNAs, generally 50–400nts in length, constitute a significant class of post-transcriptional
regulators that control gene expression for functions as diverse as membrane homeostasis, carbon
metabolism, quorum sensing, biofilm formation, etc. [128, 237]. Trans-encoded sRNAs regulate
mRNAs through short, imperfect interactions between bases. These sRNAs base pair at/near the
target RBS and block transcription or translation by preventing access to the ribosome. Others base
pair at more distant locations and may interfere with ribosome binding by other mechanisms such
as increasing ribosome binding by preventing secondary inhibitory structures from forming,
decreasing or increasing mRNA stability or affecting protein stability [237, 238]. Regulatory
sRNAs usually requires the RNA binding protein, Hfq in Gram-negative bacteria for the function
and/or stability of trans-regulated mRNAs [154], but some sRNAs do not require Hfq [239].
sRNAs may also impact translation by functioning as an asRNA.
Antisense RNAs maybe protein-coding or non-protein-coding genes and can regulate the
expression of their target genes from transcription and translation to RNA degradation at one or
more stages of the gene expression process [240]. Characteristically, they usually lack proteincoding potential with the exception of a few [241]. The untranslated region (UTR) of an asRNA
typically overlaps with neighboring genes to control transcription [242]. asRNA may be cis-acting
or trans-acting. Cis-acting asRNAs are transcribed from the opposite strand of the target gene at
the target gene locus. They have a high degree of complementarity with the target gene and
function by blocking access to the RBS or recruiting RNase to degrade a target [242, 243]. The
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end result of most cis-acting asRNA is repression [244]. On the other hand, trans-acting RNA is
transcribed from a locus that is distant from the target gene, displays a low degree of
complementarity with the target gene, can target multiple loci, form less stable complexes with
their targeting transcripts, usually encoded in an intergenic region, control translation or
degradation of target mRNA, and sometimes require RNA chaperone protein such as Hfq to
perform their functions [201, 244-246]. asRNAs have been implicated in biofilm formation by
controlling adhesion [247], iron metabolism [248], eDNA and polysaccharide export [249], etc.
The Brts are approximately 200nt in size. Their specific roles are unknown, but they lack
protein-coding potential, are found in an intergenic region, and it has been shown that Brt1 is a
negative regulator of badA and biofilm formation: in an antisense construct of Brt1, badA
expression and biofilm formation is increased suggesting that Brt1 may function in trans to
negatively regulate badA [128]. In this aim, we study the role of Brt1 in badA expression,
regulation, and biofilm formation. We hypothesize that Brt1 may act in trans to down-regulate
badA expression via direct interaction with the badA transcript independent of the downstream trp
expression. We also predict that it may bind other mRNAs and/or protein to affect protein
translation.
5.2. Materials and Methods
5.2.1. Construction of B. henselae Houston-1 Δbrt1
A deletion mutant of brt1 in B. henselae Houston-1 was constructed using a two-step
mutagenesis strategy described by Mackichan et al. (2008) [208] and in section 3.2.5. To generate
two fragments of the gene, B. henselae genomic DNA was used as a template and primer pairs
Brt1 KO F1, R1, and Brt1 KO F2, R2 was used (Table 5.1). The resulting product was ligated into
the “suicide” plasmid pJM05 at the BamHI restriction site, transformed into DH12s, confirmed by
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plasmid sequencing and then incorporated into B. henselae Houston-1 by transconjugation.
Positive clones were selected 30 μg/mL with kanamycin and counter-selected on agar containing
10% sucrose for a second cross-over event, resulting in the full-length gene being replaced with
the truncated version to generate B. henselae Houston-1 Δbrt1. The deletion mutant was confirmed
by PCR and RT-PCR using Brt1F and R (Table 3.1) to ensure the absence of the full-length brt1.

Table 5.1. Bacterial strains and primers used for aim 5.

Primer/Strain

Sequence/purpose

Brt1 KO F1

GCACGGATCCATGAAAGCTCTTTATTCCTTTG

Brt1 KO R1

CAATGCATAGAAAATTG

Brt1 KO F2

GGTGGGGAATCTTTCAAAG

Brt1 KO R2

GCACGGATCCGGGATTCTGATTCAAGTTGA

Hfq BamH1 for

GCACGGATCCGTAGAAAGATCACAACACC

Hfq Xhol for

GACACTCGAGGTTTATTCAGAGCTTTCACC

Brt1 T7 for

GAAATTAATACGACTCACTATAGGTGTTGGT

Brt1 T7 Rev

TATAACCGGGTGCGA

B. henselae Houston-1 Δbrt1

To access B. henselae phenotype in the absence of brt1

B. henselae/pNS2PTrc

Houston-1/pNS2PTrc control [250]

B. henselae/pNS2T5DsRed2

Red fluorescent protein (RFP)-expressing B. henselae
[181]

Restriction sites and T7 promoter are italicized.
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5.2.2. RNA extraction and RT-qPCR
We examined the expression of badA, brt1, and trp1 in B. henselae Houston-1Δbrt1.
Bacteria were grown for 3 days as previously described. Primer pairs badA screen 1F and 1R
(Table 2.1), Trp1 F and R (Table 3.1) and Brt1F and R (Table 3.1) were used for this experiment.
The reaction was performed as described in Aim 2.2.3.
5.2.3. Biofilm formation in B. henselae Houston-1 Δbrt1
The ability of B. henselae Houston-1Δbrt1 to form biofilms in comparison to the wild type
B. henselae Houston-1 was analyzed. The RTCA machine was used to measure biofilm formation
in real-time using the protocol outlined in Aim 2.2.2.
5.2.4. In vitro transcription of Brt1
brt1 was amplified using Brt1 T7 for and rev primers (Table 5.1). PCR amplicon was
purified and converted into RNA in vitro (Thermosci K0441). 1µg of DNA was mixed with 4µl
reaction buffer, 2µl transcript aid enzyme and 2µl each of ATP/CTP/GTP and 2µl of a 60:40 ratio
of UTP and Biotin-16-UTP (Roche 50-100-3411) in a total volume of 20µl. A non-biotin Brt1
control was made without Biotin-16-UTP. The reaction was incubated at 37°C for 5 hours, DNase1
was added to remove contaminating DNA followed by phenol:chloroform extraction. RNA was
precipitated and reconstituted in 50ul of DEPC-water. Product was confirmed on a 1% agarose gel
and quantified on Agilent Bioanalyzer.
5.2.5. Brt1 binding partners.
To analyze other binding partners of Brt1, biotinylated Brt1 RNA was incubated for an
hour with cell lysate from B. henselae grown either as a biofilm or planktonic. The protocol was
carried out as described in Aim 4.2.5. The product was prepped for RNA seq using Illumina
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stranded mRNA kit (Illumina 15031047) and samples were prepped according to the
manufacturer's protocol. Brt 1 pulldown product was analyzed using Illumina MiSeq. Data were
analyzed with Qiagen CLC workbench and quantified using the transcripts per kilobase million
values (TPM) and gene unique reads to normalize for gene length and sequencing depth. Reads
were mapped to B. henselae genome (Accession number BX897699) to identify sequences.
5.2.6. In vivo expression of the brt, trp and badA system in fleas.
7 x 108/ml of B. henselae/pNS2T5DsRed2 [181] was inoculated in 10ml of defibrinated
cat blood and fed to 600 cat fleas. On different time points (1, 3, 5, and 10) days post-infection,
both fleas and feces are collected either in trizol for RNA extraction or anesthetized by chilling at
−20°C for 5 min and then placed into a drop of PBS for dissection. RNA was extracted from both
fleas and feces using the trizol/chloroform protocol described in aim 2.2.3 above. The gut of the
anesthetized flea was pulled out using tweezers and fixed in 2% glutaraldehyde, and the fecal
matter was also fixed in 2% glutaraldehyde. For fecal biofilm preservation, 0.15% alcian blue was
added to fixative. Samples were processed as described in section 2.2.2 and imaged using both
Olympus Fluoview FV1000 confocal microscope and a Joel JSM6490LV scanning electron
microscope operated at 22Kv. Secondary images were collected as TIFF/JPEG.
5.3.

Results.
5.3.1. Biofilm formation increases in B. henselae Houston-1Δbrt1.
Biofilm formation is significantly upregulated in B. henselae Houston-1Δbrt1. We

evaluated the capability of B. henselae Houston-1/Δbrt1 to forms biofilms using the xCelligence
RTCA. Fig 5.1b shows the effect of deleting brt1 on biofilm formation. The absence of brt1
significantly upregulated adhesion, aggregation and biofilm formation. We observed that the
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adherent period is faster, much less than the time it took the wildtype, B. henselae Houston-1 to
adhere. The biofilm formed between the two strains was significantly different (P = ˂0.001, MannWhitney U). This difference was not attributed to growth rates as both strains have no significant
difference in growth rate (Fig 5.1a). Fluorescent microscopy shows that the cells within each
biofilm do not maintain the same viability (Fig 5.2a). Much like B. henselae Houston-1brt1Δ3',
the B. henselae Houston-1Δbrt1also has a significant population of cells which are either dead or
have compromised membranes. In contrast, the wild type biofilm maintains a considerable amount
of viable cells.

Fig 5.1: Growth and biofilm analysis of B. henselae Houston-1 Δbrt1. A. Growth curve of Houston-1 vs. Houston-1 Δbrt1. B.
Biofilm formation by Houston-1 vs. Houston-1 Δbrt1.

5.3.2. trp1 and badA expression are increased in B. henselae Houston-1Δbrt1.
Figure 5.2b shows that in the absence of brt1, both trp1 and badA transcription rates are
upregulated in comparison to the B. henselae Houston-1. brt1 is barely detected in B. henselae
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Houston-1Δbrt1 signifying that the gene transcription was successfully deleted. As the Brts are
quite conserved, we are unable to produce primers which were uniquely specific to Brt1 hence
primers are still capable of binding with limited complementarity to regions in other Brts.
However, irrespective of the ability to bind other Brts, Brt1 transcription was severely attenuated
in comparison to the control wild-type strain. Since growth curves between the two strains did not
significantly differ (Fig 5.1a), gene upregulation was not a factor of growth.

Fig. 5.2. Cell viability and gene expression levels in B. henselae Houston-1 Δbrt1.A. CLSM image
of a B. henselae Houston-1 Δbrt1 biofilm population using the STYO9/PI live/dead staining. B.
Expression levels of trp1 and badA overtime in a B. henselae Houston-1 Δbrt1 biofilm in
comparison to B. henselae Houston-1 (Students t-test, P ˂ 0.001). RT-qPCR bars represent the
average of 6 replicates and error bars represent the SEM.
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5.3.3. Brt1 may function as a trans-acting RNA.
Using the biotinylated Brt1, we performed a pulldown assay with streptavidin beads using
cell lysates of bacteria grown in a biofilm or as planktonic cells. Table 5.2 shows the mRNA
identified from the pulldown assay and RNA-Seq. Targets were analyzed using a 21 TPM cutoff.
Brt1 incubated with planktonic cell lysate did not pull down any mRNA. mRNAs pulled down
using a biofilm cell lysate were analyzed using unique gene reads and TPM to compensate for
large genes like badA. Genes were sorted according to their involvement in cellular processes:
stress (blue), surface adhesins and transporters (yellow), RNA biogenesis (green), metabolism
(orange), DNA binding (gray) and proteins of unknown function (no color).
Both BH16000 and mopA are annotated as heat-shock chaperone proteins which help
prevent protein misfolding (Table 5.2- blue). BadA, BH13030, BH13140, SecY, FhaB1, and
BH00460 are either surface-associated proteins or autotransporters (yellow highlight). The green
rows represent RNA polymerases and enzymes for RNA synthesis and degradation. This is
followed by the mRNAs of genes involved in metabolic functions like SucA and SdhA (orange),
DNA binding proteins like Trp 7 and hupB (gray) and proteins of unknown functions (no color).
The control, biotinylated Brt1 incubated with lysate from B. henselae grown as planktonic
cells failed to bind any mRNA. All planktonic unique reads mapped as 4 and under.
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Table 5.2. mRNAs that bind to Brt1.

78

5.3.4. B. henselae is able to survive in both cat flea and feces.
Using the B. henselae/pNS2T5DsRed2 which expresses the red fluorescent protein
(DsRed2), bacteria were resuspended in cat blood and fed to cat fleas. Fleas and fecal matter were
collected at different time points and observed. Fig 5.3a shows that the bacteria are able to grow
and replicate in the cat flea. The intensity of the DsRed protein increased as the days increased
signifying that the bacterial load increases in the gut of the flea. Fecal matter confocal image (Fig
5.3b) shows that B. henselae/pNS2T5DsRed2 is excreted in the feces and is able to grow and
replicate. The red fluorescence can be seen in the fecal matter on days 5 and 10 post-infection and
we do not observe fluorescence in the uninfected feces. Finally, scanning electron micrographs
also show that bacterial biofilm, preserved by the addition of alcian blue, is present in the fecal
matter. Tiny clusters of biofilms similar to biofilms previously observed in figures 2.1 and 2.4 are
observed in fig 5.3c. The control fecal matter does not present biofilms. This data confirms that B.
henselae is able to survive and replicate in the cat flea and feces 10 days post-infection.
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Fig. 5.3. Bacteria growth in the cat flea (C. felis) and feces. A. Confocal microscopy showing the growth of B. henselae in the gut
of C.felis. Scale bars -50µm. B. Confocal microscopy showing the growth of B. henselae in the fecal matter of C.felis. Scale bars 50µm. C. Scanning micrographs of B. henselae biofilm in the fecal matter of C.felis. Scale bars: top row-20µm, bottom row: 200µm.
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5.3.5 trp1/badA system is not expressed in the cat flea but upregulated in flea feces.
RT-qPCR was performed using RNA extracted either from the flea or flea feces. Fig 5.4
shows that the brt, trp1, and badA are barely detected in the flea. In fig 5.4b, fecal gene expression
shows that the three genes are detected however, brt1 maintained a strong, persistent presence
from day 2. badA was minimally expressed in the feces after day 2 and we observe an increase in
a trp1 from day1 to day 5 without an associated increase in badA. This suggests that Brt1, Trp1,
and BadA may not be the system involved in biofilm formation in the arthropod vector.

Fig. 5.4. Gene expression in the cat flea (C. felis) and feces. A. RT-qPCR showing the expression of brt1, trp1, and badA in C.felis.
B. RT-qPCR showing the expression of brt1, trp1, and badA in the feces of C.felis). (P ˂ 0.005 for all t-tests between the blood
RNA and flea or fecal RNA). Bars represent the average of two independent experiments. Error bars represent standard error of
the mean.

5.4.

Conclusion
As previously mentioned, trans-encoded RNAs can regulate multiple mRNAs because they

share limited complementarity with targets [246]. Most studied trans-acting RNAs regulate
translation and/or mRNA stability [245]. Some characterized sRNA binds the 5’ UTR of the target
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to occlude the RBS and subject the target mRNA for degradation [251]. A few other RNAs activate
expression of target mRNA by binding upstream of the AUG and disrupting the formation of an
inhibitory structure that sequesters the RBS [252].
The Brt RNAs have been previously implicated in the regulation of badA [128]. In this
aim, B. henselae Houston-1 Δbrt1 strain showed an increase in adhesion and biofilm formation
and a significant upregulation for the expression of the trp1 gene and badA expression. This
suggests that Brt1 negatively regulates badA. The Brts/Trps are found in an intergenic region; a
characteristic of genes acquired by horizontal gene transfer.
We also observe that Brt1 may exert trans-acting roles on other mRNA asides from BadA.
Gene expressions differ greatly in biofilm compared to planktonic gene profiles. When bacteria
are exposed to higher temperatures, heat shock proteins are induced to cope with damage to
proteins. Bacteria are able to sense changes in temperature using nucleic acids (DNA or RNA) or
proteins [253]. In table 5.2, we observe that heat shock proteins located in different areas of the
genome interact with Brt1 mRNA. We also observe that Brt1 binds BadA mRNA possibly in a
repressive manner. B. henselae Houston-1Δbrt1 presents increased badA and biofilm formation
and an antisense knockdown of Brt1 also upregulated badA expression [128]. Fha mediates
adhesion in Gram-negative bacteria and in B. henselae [110, 133]. SecY, a secretory pathway
component is associated with decreased biofilm formation [254, 255] and ion channels typically
enable communication between cells in a biofilm [256]. RNA polymerases ropB and rpoC catalyze
transcription of DNA to RNA while Ribopolynucleotide nucleotidyltransferase has been
implicated in biofilm formation [257]. SucA, sdhA, and homologs of thiG1 have all been
implicated in biofilm formation: downregulation of the genes severely affected biofilm formation
[258-261]. We observed that control biotinylated Brt1 incubated with planktonic cell lysate did
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not bind any of this mRNAs perhaps signifying that the Brt1 RNA is not only expressed under
conditions consistent with mammals but also required an initial adhesion to become active.
In vivo expression using B. henselae/pNS2T5DsRed2 confirms that B. henselae is able to
grow and replicate in the gut of the cat flea vector. The fluorescence of the DsRed2 increased as
the days increased suggesting increased bacterial load. The fecal matter of the cat flea was
examined, and B. henselae biofilm was observed in the feces. Confocal microscopy also detected
B. henselae/pNS2T5DsRed2 fluorescence confirming their growth and viability in cat flea feces
as previously published [177]. To confirm the regulatory system used to form biofilm in the cat
flea, RT-qPCR primers for brt1, trp1, and badA were used to detect gene expression. Fig 5.4
confirms that the system is minimally expressed in the cat flea and may not be responsible for
biofilm formation. We noted that B. henselae/pNS2T5DsRed2 used to inoculate the blood
expresses high levels of brt1 but brt1, trp1, and badA expression was downregulated in the flea
despite the increasing presence of the bacteria in the flea gut (Fig 5.3a). However in the flea feces
for day 2, we observe complete repression of the Brt gene, upregulation of Trp1 and a slight
expression of badA. Brt1 expression increases in day three and trp and badA expression reduces
(Fig 5.4b). Also, fig 2.6 shows that badA is significantly downregulated in vitro under conditions
that mimic the arthropod vector. We propose that the brt1/trp1/badA regulatory system is only
used under conditions relative to the mammalian host as supported by the low expression of the
system in fleas. We also propose that this unique regulatory system may be responsive to
environmental conditions in the mammalian host and the initial adhesion stages of a biofilm. This
is supported by the fact that Brt1 did not bind mRNA of cells grown as planktonic cells at 37°C.
To summarize, Brt1 contains a transcript terminator for trp1 but may also act as an asRNA
for degradation of the BadA mRNA. We further propose that it also acts as a trans-regulating RNA
83

to regulate mRNAs of other outer membrane proteins, stress response, and metabolic genes as well
as genes controlling transcription and RNA stability (rpoB, rpoC, mopA, and pnp) to target
mRNAs. While brt/trp/badA genes were detected in the cat feces, the expression levels were
significantly lower than the expression levels in mammalian conditions hence it is possible that
biofilm formation in the arthropod vector occurs through a different regulatory pathway.
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Chapter 6: Discussion
Bacteria are one of the most abundant organisms on earth with current estimates of at least
1030 with ten-fold uncertainty [262, 263]. Bacteria occupy a variety of ecological niches that give
their inhabitants advantages, but a small portion of them can cause diseases [264-266]. Bacterial
survival is dependent upon the ability to sense and rapidly adapt to specific changes within the
immediate environment. Temperature, heme, pH, nutrient source, and concentration of
metabolites, ions, and oxygen are some variable environmental conditions known to influence
bacterial gene expression [98, 267, 268].
Biofilms are considered the default mode of growth for bacteria [269]. Bacteria form
biofilms in response to environmental cues like change in temperature, nutrient availability or as
a defense mechanism from insult by the host cell [270]. Biofilm formation is recognized as an
essential aspect of many, if not most bacterial diseases, including native and prosthetic valve
endocarditis, osteomyelitis, dental caries, otitis media, medical device-related infections, ocular
implant infections, and chronic lung infections in cystic fibrosis patients [271]. In this thesis, we
show that B. henselae is capable of forming a biofilm and that the bacteria expresses genes which
contribute to optimal survival and fitness in a stressed environment.
From Fig 2.1, we observed that B. henselae is capable of forming a biofilm within 48 hours
starting with adhesion and aggregation. The aggregates form microcolonies, grow and produce
biofilms. BadA, a TAA found in B. henselae, is responsible for the adhesion and aggregation phase
and we observe that biofilm cells transcribe more badA, unlike the planktonic counterpart (Fig
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2.2a). In the absence of badA, B. henselae cells are able to form a weak biofilm compared to badA
expressing strains (Fig 2.3). This is because badA expressing strains tend to go through the
adhesion and aggregation phase much faster to form colonies and eventually biofilms (Fig 2.3;
enlarged image). In Fig 2.3b, we observed that using the standard CV stain, badA strains still have
more biomass, fewer cells floating in the growth media, and maintained viable cells within the
biofilm (Fig 2.3c, Fig 2.3d). In contrast, the B. henselae Houston-1 ∆badA had less biomass post
biofilm assay, more cells in the growth media and dead cells within the weak biofilm (Fig 2d). In
fig. 2.4, we ascertained that both B. henselae Houston-1 and B. henselae Houston-1
∆badA/pNS2PTrcbadA are both able to grow in a 3D fashion wrapping aggregates around the
branches of the scaffold and formed biofilms which enveloped the scaffold. B. henselae Houston1 ∆badA, in contrast, lacked the ability to form considerable-sized aggregates with inferior
biofilms. We observed that a B. henselae Houston-1 biofilm contains polysaccharides, protein, and
eDNA (Fig 2.4a) and that treatments with enzymes capable of digesting the major component
either reduced the ability of the bacteria for form biofilms or severely affected a mature biofilm
(Fig 2.5b).
Previously, it was briefly discussed that B. henselae has to adapt to the different
environmental condition of both the cat flea and the mammalian vector. Mimicking the conditions
of both vector and host in vitro shows that B. henselae favor conditions related to mammalian
hosts. It is able to grow and form a biofilm with viable cells and express badA at a temperature of
37°C and pH 7.2 consistent with mammals. Under conditions relative to the cat flea, it is still able
to grow, form biofilms and express badA but in comparison to mammalian host conditions, this
ability is significantly downregulated.
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Biofilm regulation has been linked to sRNAs and proteins which regulate gene
transcription and protein translation. Both sRNAs and proteins have been linked to biofilm
regulation in B. henselae Houston-1 [98, 128]. RNAs play a pivotal role in bacteria; RNA
regulators are ubiquitous, often well conserved and can exceed the number and diversity of protein
regulators [237]. Understanding RNA function will elucidate the pathway for bacterial
pathogenesis and survival like biofilm formation. Small regulatory RNAs (sRNAs) are now
considered to be significant gene expression regulators in bacteria after transcription. Their
importance in probably all bacterial species is related to their variety as well as the diversity of the
target genes physiological functions.
In chapter three, the impact of Brt1, an sRNA with a 3' terminating loop on trp1, a TF
linked as a positive regulator of badA was studied. trp1 was minimally transcribed in B. henselae
Houston-1 under the conditions used for RNA-seq analysis by Tu et al [128]. Trp1 is found 15nt
downstream of a highly expressed Brt1 (Fig 1.1a, Fig 1.2b). The proximity of trp1 and brt1 and
the lack of an open reading frame/ internal promoter in brt1 dismisses the probability of trp1
bearing a native promoter bolstering the idea that trp1 is transcribed from the brt1 promoter. The
evidence that brt1 is highly transcribed and the downstream gene is barely transcribed suggests
that the stem-loop at the end of the Brt1 RNA (Fig 1.1a), is responsible for a premature transcript
termination preventing the downstream trp gene from being transcribed (Fig 1.1c). To resolve this
hypothesis, the brt promoter and gene with and without the 3' stem-loop was cloned upstream of
the gfp gene (Fig 3.1a). gfp transcription was driven from the brt1 promoter and we studied the
impact of the 3' loop on gfp. In Fig 3.2a, we noticed that in B. henselae Houston-1/pNS2 brt1Δ3'gfp which lacks the 3' stem-loop, gfp is transcribed and GFP expression is observed
microscopically. B. henselae Houston-1/pNS2 brt1-gfp, a clone which harbors the full-length Brt1
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terminated the transcription of gfp while the control B. henselae Houston-1/pns-gfp was unable to
transcribe gfp because it lacked a promoter. Using a flow cytometer to confirm Fig 3.2a
microscopy images, we observed that GFP intensity in B. henselae Houston-1/pNS2 brt1Δ3'-gfp
was about 30x more intense than B. henselae Houston-1/pNS2 brt1-gfp and B. henselae Houston1/pNS2-gfp. There was no statistical difference between GFP expression in B. henselae Houston1/pNS2 brt1-gfp and B. henselae Houston-1/pNS-gfp. To reconfirm this, the 3' region of Brt1 was
deleted to create B. henselae Houston-1 Brt1Δ3' (Fig 3.3a). Deletion of the terminating region
increased aggregation, biofilm formation and an upregulation of the trp1 and badA expression (Fig
3.3c, Fig 3.4b).
The trp1 gene found downstream of this terminating region codes for a HTH-XRE-TF
capable of binding and regulating gene transcription. A previous publication presented evidence
that trp1 is a positive regulator of badA; overexpression of trp1 results in an increase in badA
transcription [128]. In chapter four, we examined the relationship between trp1 and badA. As trp1
is a TF, we wanted to see if it had a direct relationship with badA as a gene regulator. Trp1 protein
was His-tagged and purified using a pET28a plasmid in E.coli. The promoter region of badA was
amplified, biotinylated, incubated with Trp1 and subjected to electrophoresis. EMSA, a retardation
assay was performed and a shift in mobility was noted. In Fig 4.1, lane 1, the biotinylated badA
promoter region migrated quicker in contrast to the slow mobility of the band in lane 2 which
contains the biotinylated badA promoter region and Trp1 protein. A discernible shift is observed
confirming that badA putative promoter is bound to Trp1 increasing the size of the band. This
increase in size causes the band to migrate slowly. In lane 3, in the presence of a competitive
inhibitor; the intensity of the migrated band is reduced confirming that the competitive inhibitor,
a nonbiotinylated DNA, is able to bind and displace the biotinylated DNA. To confirm that Trp1
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is able to bind the promoter region of badA only, a 352 bp amplicon of the 3' coding region of
badA was biotinylated (lane 4) and incubated with Trp1 and no band shift is noted (lane 5).
Furthermore, incubation of Trp1, badA promoter region and the biotinylated coding region of badA
did not produce a badA promoter region displacement (lane 6). If Trp1 is responsible for binding
badA, and badA is responsible for biofilm formation, then an increase in both gene expression
should be observed in a biofilm. To further confirm this theory, RT-qPCR data in fig. 4.2 shows
that in comparison to planktonic cells, biofilm cells express more trp1 and badA. it is noteworthy
to point out that since trp1/badA is needed for the first stages of biofilm formation, the expression
decreases over time once a biofilm is formed [98]. This is likely because of the anchoring abilities
of the EPS. Once a biofilm is formed, the community uses the EPS to anchor colonies to the surface
eliminating the need for the BadA adhesin. Typically, some genes have more than 1 transcription
factor. Fig 4.3 shows that five other proteins are capable of binding the badA promoter region. Of
notable interest is Trp3; a member of the 9 copies of the trp gene family and a HTH-XRE-TF.
Clpb, a stress-induced multi-chaperone protein that binds possibly to help stabilize interactions
between mRNAs and proteins was also observed. To summarize chapter four, Trp1 is a positive
regulator which binds the badA promoter region to regulate gene expression.
Regulatory RNAs may present as small trans-encoded RNAs (sRNAs) regulating one or
more target genes located elsewhere on the chromosome, or as cis-encoded antisense RNAs
(asRNAs) that overlap and complement their target genes encoded on the opposite genomic locus
DNA strand as reviewed in Sesto et al. (2013) [151]. The regulatory function of non-coding RNAs
is often closely linked to RNases activity that either promotes specific transcript cleavage and
degradation or prevents RNase transcript recognition and degradation of the transcript increasing
the stability of the target RNA in the cell [272]. A knockdown antisense strain of Brt1 showed
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increased biofilm formation and upregulation of badA [128]. Deletion of the brt1 presented
increased biofilm formation (Fig 5.1b) and upregulation of trp1 and badA confirming that in B.
henselae Houston-1, brt1 is a negative regulator of trp1 and badA (Fig 5.2b). In contrast to the
wildtype B. henselae Houston-1, the viability of cells within the B. henselae Houston-1Δbrt1
biofilm is severely reduced (Fig 5.2a). We observe that a biotinylated Brt1 pulled down BadA
mRNA amongst others. Since badA and Brt1 are located in different areas of the genomes, Brt1
may also function as antisense trans-regulating RNA. It is also noted that Brt1 is able to regulate
other genes related to surface adhesion, metabolism, stress response and RNA synthesis. With
most of the genes previously implicated in biofilm formation. In summary, Brt1 is a negative
regulator which may function in cis to terminate trp1 transcription or in trans to regulate BadA
mRNA.
6.1

Potential treatment options/drug targets
Environmental changes influence virulence gene expression, and pathogens are acquiring

resistance or developing tolerance to antibiotics. Antibiotic resistance and tolerance in the
treatment of bacterial infections is a serious and growing problem. Antibiotic resistance is an
acquired genetic change in the bacteria while antibiotic tolerance is the ability of the otherwise
susceptible bacteria to survive transient antibiotic exposure typically due to the protection
conferred by a biofilm. A recent publication estimates >10,000,000 deaths per year associated with
antibiotic-resistant and tolerant infections [273]. Most clinically approved antibiotics target
growth/integrity of bacterial cell walls, translation, and replication/segregation of DNA, while
RNAs, transcription process and factors appear to be an underused target. New drug targets are
required to help combat antibiotics resistance. Transcription is the process by which the enzyme
RNA polymerase (RNAP) synthesizes RNA from a template DNA. There are currently two
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antibiotics that target bacterial RNAP on the market: rifamycin which binds RNAP to hinder the
growth of RNA product [274] and fidaxomicin/lipiarmicin speculated to bind the switch region to
prevent the formation of transcription process [275, 276]. As reviewed by Cong et al. (2016) [277],
bacterial transcription is an excellent target for novel antibacterial development for the following
reasons: (i) transcription is an essential process for cell viability; (ii) bacterial RNAP and the
associated transcription factors are highly conserved, allowing for the potential development of
broad-spectrum anti-transcriptional antibiotics [278]; (iii) eukaryotic RNAP is not similar to the
bacterial homolog at the sequence level suggesting low potential cytotoxicity [279]. This novel
idea disrupts the transcription process and is an untapped area for bacterial disease treatments. All
of the regulatory genes studied here may be used as a potential drug target.
6.1.1. RNA targets
Anti-infective RNA based drugs have gained significant attention mostly because RNAs
play multifunctional roles that regulate disease infection and progression at multiple levels. In
mammalian cells, antisense oligonucleotides that target mRNA by complementary base pairing
recognition have been used to treat familial hypercholesterolemia [280]. Aminoglycoside
antibiotics are oligosaccharides containing several ammonium groups and bind the aminoacyltransfer RNA (tRNA) decoding site (A site) on the 16S rRNA [281, 282]. Indeed, several
compounds have been developed that kill bacteria by mimicking ligands for riboswitches
controlling essential genes, demonstrating that regulatory RNA elements are druggable targets
[283]. Some antibiotics target pockets that have the ability to bind specific ligands and RNA can
fold into 3D structures with binding sites for specific ligands [284]. Literature also shows that the
ribosome-antibiotic complex formed for drugs that target the ribosome, bind rRNAs and not
ribosomal protein [285]. Since the first discovery of asRNAs in prokaryotes, antisense
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oligonucleotides have been used as drug targets when Zamecnik and Stephenson found one that
could inhibit viral replication and protein synthesis in the viral RNA of the Rous sarcoma virus in
1978 [286]. The first FDA approved drug, fomivirsen, was developed for the treatment of
cytomegalovirus retinitis in patients with AIDS.
6.1.2 Adhesins
In light of the resurgence of infectious diseases, membrane proteins are prime candidates
for the development of urgently needed novel anti-infectives [287]. One of the first steps during
bacterial infection is adhesion of the pathogen to host cells. Adhesion interference is, therefore, an
effective way of preventing or treating bacterial infections. Small peptides are being developed to
target P. aeruginosa adhesion [288, 289].
6.1.3 Transcription factors
TFs are also good integration points for multiple signaling pathways. They control a
plethora of pathogenic and virulence factors and genes in bacteria. Recent work in drug discovery
has shown that TFs are susceptible to drug inhibition and are being employed to inhibit
downstream signaling [290]. While this is shown to lack specificity mostly because of redundancy
in the signaling cascade, some have been shown to disrupt protein-protein and protein–DNA
interactions in vitro.
In conclusion, we have developed a hypothetical model of biofilm regulation in B. henselae
Houston-1 (Fig 6.1). We speculate that B. henselae Houston-1 cells undergo an initial adherence
step within the first 8-24 hours after contact with a surface as supported by fig 2.1a. This initial
contact releases a signal sensed by the brt1 TF which binds the brt1 promoter region. The Brt1
and Trp1 are transcribed as a full-length mRNA evidenced by the increased expression of trp1 in
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a biofilm in 24-48 hours (Fig 4.2). Trp1 is translated and binds the badA promoter region to activate
gene badA transcription (Fig 4.1). BadA expression, in turn, promotes aggregation and an
irreversible surface adhesion (Fig 2.1b-c). Once aggregation is optimal, we speculate that a
different signal, perhaps the auto inducer responsible for quorum sensing may bind to Brt1 to
induce the formation of the 3' stem-loop initiating Trp1 transcript termination. This is supported
by fig.4.2 where we observe a decrease in Trp1 from day 3: from fig 2.1, a biofilm is already
formed by day 3(72 hours). Brt1 is transcribed as a 3' stem-loop RNA capable of exerting transacting RNA abilities on BadA to target the badA mRNA for degradation (Fig 4.2-badA expression
decreases) and on other mRNAs required for stress response, RNA stability, EPS metabolism, etc.
(Table 5.2). EPS is synthesized and biofilm is formed. This brt/trp/badA regulation is minimally
functional in the C.felis arthropod vector signifying that perhaps a different outer membrane may
serve as the adhesin for biofilm formation (Fig 5.4). Data presented within this study are the first
to identify and experimentally characterize an adhesin, transcriptional regulator and RNA
responsible for biofilm formation in B. henselae.
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Fig 6.1: A hypothesized model for biofilm regulation by B. henselae. B. henselae undergoes an initial adhesion stage which signals for the transcription of Brt1. Brt1 and Trp1 are
transcribed from the Brt1 promoter. Trp1 activates badA transcription and BadA helps aggregate and adhere cells to a surface. Once aggregation reaches the optimum level, a
feedback loop is generated and a stimulus binds Brt1 causing the 3' loop. This 3' terminating loop prevents Trp1 transcription. Brt1 binds BadA mRNA to degrade it while binding
the mRNA of other genes to either degrade or promote stability. We predict that metabolic genes are positively regulated by Brt leading to EPS synthesis and biofilm formation.
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